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ABSTRACT	  
	  Both	  TRPML1	  and	  TRPML3	  are	  members	  of	  the	  mucolipin	  subfamily	  of	  Transient	  Receptor	  Potential	  (TRP)	  channels.	  They	  have	  been	  implicated	  in	  endolysosomal	  functions	  such	  as	  divalent	  cation	  release,	  luminal	  pH	  regulation,	  autophagy	  and	  vesicle	  trafficking.	  Interestingly,	  whereas	  TRPML1	  is	  almost	  extensively	  localized	  in	  lysosomes,	  TRPML3	  is	  typically	  found	  in	  both	  lysosomes	  and	  the	  plasma	  membrane	  (PM).	  It	  has	  been	  shown	  that	  TRPML3	  localization	  depends	  on	  TRPML1,	  but	  the	  mechanism	  remains	  unknown.	  Recently,	  a	  number	  of	  TRPML1	  mutants	  have	  been	  reported	  to	  be	  either	  retained	  in	  the	  endoplasmic	  reticulum	  (ER)	  or	  preferentially	  targeted	  to	  the	  PM.	  Coexpressing	  these	  mutants	  with	  either	  wild	  type	  TRPML3	  or	  a	  non-­‐functional	  ER-­‐retained	  mutant,	  TRPML3-­‐KK,	  I	  examined	  how	  differentially	  targeted	  TRPML1	  proteins	  affect	  TRPML3	  localization.	  I	  show	  that	  while	  the	  wild	  type	  TRPML1	  decreased	  the	  PM	  targeting	  of	  TRPML3,	  the	  PM-­‐targeted	  TRPML1	  mutants	  did	  not	  enhance	  PM	  localization	  of	  TRPML3.	  Interestingly,	  not	  only	  the	  wild	  type	  TRPML1	  brought	  TRPML3-­‐KK	  to	  lysosomes,	  but	  also	  TRPML3	  brought	  the	  ER-­‐retained	  TRPML1-­‐KK	  mutant	  to	  these	  acidic	  organelles.	  Moreover,	  coexpression	  of	  TRPML-­‐KK	  not	  only	  reduced	  TRPML3-­‐mediated	  Ca2+	  response	  to	  a	  TRPML	  agonist,	  ML-­‐SA1,	  but	  also	  nearly	  abolished	  PM	  localization	  of	  TRPML3.	  Activation	  of	  
	  v	  
heteromultimeric	  TRPML1/3	  channels	  by	  ML-­‐SA1	  significantly	  increased	  the	  PM-­‐localized	  TRPML3,	  while	  the	  TRPML	  channel	  inhibitor,	  ML-­‐SI1,	  did	  not	  decrease	  the	  PM-­‐localized	  TRPML3.	  Consistently,	  co-­‐expressing	  a	  non-­‐functional	  lysosome-­‐localized	  TRPML1	  mutant,	  TRPML1-­‐F465L	  with	  TRPML3	  decreased	  the	  PM-­‐localized	  TRPML3	  as	  efficiently	  as	  wildtype	  TRPML1.	  I	  conclude	  that	  while	  the	  lysosome	  targeting	  sequence(s)	  is	  important	  for	  sorting	  TRPML	  channels	  out	  of	  ER-­‐Golgi	  network,	  the	  ion-­‐conducting	  function	  is	  important	  for	  TRPML	  channels	  to	  be	  trafficked	  to	  plasma	  membrane,	  but	  not	  for	  their	  endocytosis.	  	  Genetically	  encoded	  fluorescence	  probes	  have	  gained	  popularity	  nowadays	  because	  of	  the	  ease	  to	  target	  them	  to	  specific	  subcellular	  compartments.	   	   GCaMPs	  are	  widely	  used	  genetically	  encoded	  calcium	  indicators,	  which	  exhibit	  dramatic	  increases	  in	  fluorescence	  upon	  binding	  to	  Ca2+.	  In	  order	  to	  assess	  Ca2+	  signals	  generated	  from	  opening	  of	  TRPML1	  channel,	  as	  well	  as	  that	  from	  lysosomes,	  I	  have	  engineered	  two	  constructs:	  with	  GCaMP5G	  fused	  to	  either	  the	  C-­‐terminus	  of	  TRPML1	  or	  that	  of	  lysosomal-­‐associated	  membrane	  protein	  1	  (LAMP1).	  To	  my	  surprise,	  however,	  both	  engineered	  probes	  were	  able	  to	  sense	  Ca2+	  released	  from	  ER	  and	  Ca2+	  entry	  through	  PM.	  They	  did	  not	  show	  specific	  utility	  in	  detecting	  lysosomal	  Ca2+	  release.	  Trafficking	  of	  LAMP1	  and	  TRPML1	  were	  apparently	  disrupted	  with	  the	  conjugation	  of	  GCaMP5G.	  Specifically,	  LAMP1-­‐GCaMP5G	  and	  TRPML1-­‐GCaMP5G	  showed	  prominent	  PM	  localization,	  unlike	  the	  GFP-­‐tagged	  LAMP1	  and	  TRPML1,	  which	  preferentially	  target	  to	  the	  lysosomes.	  In	  addition,	  TRPML1-­‐GCaMP5G	  also	  appeared	  in	  enlarged	  vesicles	  with	  bright	  green	  fluorescence.	  These	  results	  suggest	  that	  cautions	  should	  be	  taken	  when	  using	  engineered	  GCaMPs	  to	  study	  subcellular	  localized	  Ca2+	  signals	  using	  tagged	  proteins.	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Abbreviation	  
	  Cy5	   Cyanine	  Dye	  5	  CCH	   Carbachol	  ER	   Endoplasmic	  Reticulum	  GCaMP	   GECI,	  Genetically	  Engineered	  Calcium	  Indicator	  GFP	   Green	  Fluorescence	  Protein	  GPN	   glycyl-­‐L-­‐phenylalanine	  2-­‐naphthylamide	  HEK	   Human	  Embryonic	  Kidney	  HEPES	   2-­‐[4-­‐(2-­‐hydroxyethyl)piperazin-­‐1-­‐yl]ethanesulfonic	  acid	  IP3	   Inositol	  1,4,5-­‐trisphosphate	  KCl	   Potassium	  Chloride	  LAMP1	   Lysosome	  Associated	  Membrane	  Protein	  1	  LAMP2	   Lysosome	  Associated	  Membrane	  Protein	  2	  MgCl2	   Magnesium	  Chloride	  ML-­‐SA1	   Mucolipin	  Synthetic	  Agonist	  1	  ML-­‐SI1	   Mucolipin	  Synthetic	  Inhibitor	  1	  NaCl	   Sodium	  Chloride	  PBS	   Phosphate	  Buffered	  Saline	  PEI	   Polyethylenimine	  PFA	   Paraformaldehyde	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PI(3,5)P2	   Phosphatidylinositol	  3,5-­‐bisphosphate	  PI(4,5)P2	   Phosphatidylinositol	  4,5-­‐bisphosphate	  RT-­‐PCR	   Reverse	  Transcriptase	  Polymerase	  Chain	  Reaction	  TRP	   Transient	  Receptor	  Potential	  TRPML1	   Transient	  Receptor	  Potential	  Mucolipin	  1	  TRPML3	   Transient	  Receptor	  Potential	  Mucolipin	  3	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Chapter	  1	  Introduction	  
	  2	  
1.1	  Lysosomes	  and	  their	  functional	  regulation	  by	  a	  variety	  
of	  lysosome	  membrane	  proteins	  	  Lysosomes,	   the	   subcellular	   organelles	   discovered	   about	   60	   years	   ago	   (1),	  represent	   major	   intracellular	   compartments	   for	   degradation	   of	   a	   variety	   of	  cellular	  substances,	  including	  proteins	  and	  lipids	  (2).	  Through	  transporters	  (3)	  or	   by	   diffusion,	   the	   building	   blocks	   produced	   from	   the	   breaking	   down	   of	  macromolecules	   become	   available	   to	   other	   cellular	   synthesis	   machinery	   to	  maintain	   cell	   homeostasis.	   The	   degradation	   function	   of	   lysosomes	   is	  accomplished	   by	   around	   60	   hydrolases	   in	   the	   lumen	   of	   lysosomes	   (4),	  which	  work	  optimally	  at	  the	  pH	  of	  ~4-­‐5.	  V-­‐ATPase,	  the	  proton	  pump,	  consumes	  ATP	  to	  actively	   pump	   protons	   into	   lysosomes,	  maintaining	   the	   acidic	   environment	   of	  the	   lysosomal	   lumen.	   Lysosomes	   can	   degrade	   both	   extracellular	   and	  intracellular	   materials	   delivered	   to	   the	   acidic	   organelles	   through	   a	   variety	   of	  vesicle	  trafficking	  pathways.	  	   Extracellular	  materials,	   through	   endocytosis,	   are	   trafficked	   to	   lysosomes	   via	   a	  series	   of	   fusion	   and	   sorting	   events,	   during	  which	   an	   early	   endosome	  matures	  and	   becomes	   late	   endosome	   and	   eventually	   fuses	   with	   lysosome	   to	   have	   the	  contents	   degraded	   (5).	   In	   addition	   to	   maintaining	   material	   homeostasis,	   the	  delivery	  of	  extracellular	  molecules	  to	  lysosomes	  also	  play	  roles	  in	  termination	  of	  signaling	   events,	   such	   as	   activin/nodal,	   wnt3a	   and	   EGFR	   (6-­‐8).	   Intracellular	  degradation	   via	   lysosomes	   typically	   starts	   from	   autophagy,	   during	   which	  impaired	   proteins	   or	   organelles	   are	   first	   sequestered	   by	   autophagosomes,	  which	   subsequently	   fuse	   with	   lysosomes	   to	   form	   autolysosomes	   to	   have	   the	  vesicular	  contents	  digested	  eventually.	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In	  addition	  to	  the	  hydrolases	  that	  carry	  out	  degradation	  to	  facilitate	  lysosomes	  to	   fulfill	   the	   role	   as	   the	   recycling	   center,	   a	   considerable	   number	   of	   lysosome	  membrane	   proteins,	   besides	   those	   involved	   in	   forming	   the	   proton	   pump,	   also	  play	  important	  roles	  in	  assisting	  lysosome	  functions	  (9).	  For	  example,	  Rab7,	  an	  small	  GTPase,	  controls	  aggregation	  and	  fusion	  of	  late	  endocytic	  structures	  with	  lysosomes	   and	   is	   essential	   for	   maintaining	   lysosome	   biogenesis	   (10).	   More	  recently,	   lysosomal	   ion	   channels	   were	   discovered	   to	   modulate	   lysosomal	  functions	   and	   cell	   health.	   For	   instance,	   Two	   Pore	   Channels	   (TPCs)	   are	   key	  regulators	   of	   NAADP-­‐induced	   global	   Ca2+	   signaling	   that	   is	   initiated	   from	  lysosomes	   (11);	   TRPML1	   is	   a	   non-­‐selective	   cation	   channel	   preferentially	  expressed	   in	   lysosomes.	   Genetic	   mutations	   of	   TRPML1	   have	   been	   associated	  with	  a	  lysosomal	  storage	  and	  neurodegenerative	  disease,	  mucolipidosis	  type	  IV	  (12).	   	  	  
1.2	  Lysosomal	  calcium	  signaling	  and	  TRPML	  channels.	  
	   Lysosomes	   are	   not	   only	   organelles	   that	   control	   cellular	   homeostasis,	   but	   also	  storage	   pools	   of	   intracellular	   Ca2+.	   Because	   lysosomes	   and	   other	   intracellular	  vesicles	  move	  constantly	   inside	   the	  cells,	   they	  can	  be	  regarded	  as	  mobile	  Ca2+	  stations.	  TRPML	  proteins	  form	  Ca2+-­‐permeable	  channels	  preferentially	  localized	  on	   lysosomes.	   They	   have	   been	   implicated	   to	   play	   critical	   roles	   in	   lysosome	  trafficking	   and	   lysosome	   biogenesis	   based	   on	   studies	   from	   both	   cellular	   and	  whole	   animal	   levels	   (13).	   Given	   the	   fact	   that	   lysosomes	   are	   highly	   dynamic	  vesicles	   (14),	   and	   local	   Ca2+	   release	   from	   lysosomes	   triggers	   a	   series	   of	   cell	  signaling	   events,	   understanding	   the	   regulation	   and	   function	   of	  lysosome-­‐localized	  TRPML	  channels	  is	  an	  important	  goal	  for	  cell	  biologists.	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   Mammalian	  genomes	  encode	  three	  genes	  for	  TRPML	  channels,	  TRPML1-­‐3,	  all	  of	  which	   have	   six	   putative	   transmembrane	   segments	   and	   belong	   to	   transient	  receptor	  potential	  (TRP)	  superfamily.	  While	  the	  properties	  of	  TRPML2	  channel	  remain	   to	   be	   unveiled,	   those	   of	   TRPML1	   and	   TRPML3	   have	   been	   studied	   in	  greater	  details.	  TRPML1	  is	  expressed	  in	  the	   lysosomes	  in	  essentially	  every	  cell	  type	   (12),	   and	   defects	   in	   the	   calcium-­‐permeable	   TRPML1	   channel	   lead	   to	  enlarged	   vesicles,	   within	   which	   reside	   undigested	   lipids	   (15),	   underlying	   the	  molecular	  pathological	  mechanism	  of	  mucolipidosis	  type	  IV.	  In	  Drosophila,	  there	  is	   only	   one	   trpml	   gene.	   The	   compromised	   trpml	   gene	   functions	   cause	  accumulation	   of	   apoptotic	   cells	   in	   the	   Drosophila	   brain,	   due	   to	   defects	   in	  autophagy,	  the	  primary	  mechanism	  for	  animals	  to	  clear	  dead	  cells	  (16,	  17).	  	  TRPML3	  is	  expressed	  in	  both	  lysosomes	  and	  on	  the	  plasma	  membrane	  (18).	   It	  has	  a	  more	  restricted	  tissue	  distribution	  than	  TRPML1.	  The	  mRNA	  analysis	  by	  RT-­‐PCR	  and	  in	  situ	  hybridization	  revealed	  the	  existence	  of	  TRPML3	  in	  thymus,	  spleen,	   lung,	  eye	  and	  epithelial	  cells	   (19,	  20).	  TRPML3	  also	   functions	  as	  a	  Ca2+	  permeable	   channel.	   A	   gain-­‐of-­‐function	   mutant	   of	   TRPML3	   in	   mice	   leads	   to	  varitint–waddler	  phenotype,	  characterized	  by	  deafness	  and	  patched	  fur,	  which	  presumably	  originates	  from	  excessive	  Ca2+	  entry	  into	  the	  cells	  (21,	  22).	   	  
	  
1.3	  Subcellular	  localizations	  of	  TRPML1	  and	  TRPML3	   	  
Lysosome	   functionality	   is	   dependent	   on	   the	   proteins	   that	   reside	   on	   the	  organelle.	  In	  this	  sense,	  proper	  trafficking	  of	  the	  appropriate	  proteins	  destined	  to	   the	   lysosomes	   is	   important	   for	   the	   functionality	   of	   lysosomes.	   It	   is	   well	  established	   that	   the	   lysosomal	   luminal	   proteins	   make	   use	   of	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mannose-­‐6-­‐phosphate	   receptor	   (M6PR)	   (23,	   24)	   for	   the	   transport	   from	  ER	   to	  lysosomes.	   However,	   how	   lysosomal	   membrane	   proteins	   target	   to	   their	  subcellular	   locations	   is	   not	   completely	   understood,	   despite	   their	   important	  functions.	   The	   discovery	   of	   lysosome-­‐targeting	   signal	   peptides	   provided	   an	  explanation	  for	  the	  trafficking	  of	  a	  substantial	  number	  of	  lysosomal	  membrane	  proteins.	  Consensus	  peptide	  sequences,	  including	  NPXY	  (X	  stands	  for	  any	  amino	  acid),	   YXXΘ	   (Θ	   stands	   for	   hydrophobic	   amino	   acids)	   and	  di-­‐leucine	  motif,	   are	  generally	   regarded	   as	   the	   elements	   that	   direct	   transmembrane	   proteins	   to	  lysosomes.	   	  	  TRPML1,	  the	  polypeptide	  of	  which	  bears	  more	  than	  one	  of	  the	  signal	  peptides	  described	  above,	   is	   localized	   in	   the	   lysosome	  membrane	  and	  well	   co-­‐localized	  with	   the	   lysosome	  marker	  LAMP1.	  TRPML3,	  however,	  although	  also	  predicted	  to	  contain	  a	  putative	   lysosome	  targeting	  sequence,	   is	  partially	   localized	   to	   the	  plasma	  membrane	   (25).	  When	   co-­‐expressed	  with	   TRPML1,	   TRPML3	   becomes	  much	   less	   localized	  to	  the	  PM,	   indicating	  that	   there	  could	  be	  a	  hierarchy,	  with	  which	  TRPML3	   localization	   is	   regulated	  by	  TRPML1	   (18).	  A	   subsequent	   study	  proposed	   that	   TRPML1	   and	   TRPML3	   could	   form	   heteromultimeric	   channels	  (26),	   based	   on	   the	   calcium	   imaging	   and	   whole-­‐cell	   electrophysiology	   results	  obtained	   from	   cells	   that	   co-­‐expressed	   the	   wildtype	   channel	   subunit	   of	   one	  TRPML	  subtype	  together	  with	  a	  dominant-­‐negative	  mutant	  of	  the	  other	  TRPML	  isoform.	   	  	  
1.4	  The	  role	  of	  TRPML	  channels	  in	  vesicle	  trafficking	  
The	   detailed	   molecular	   mechanism(s)	   by	   which	   TRPML	   channels	   regulate	  membrane	  trafficking	  remains	  to	  be	   investigated.	  Biochemical	  and	  cell	  biology	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evidence	   indicates	   that	   TRPML1	   functions	   in	   regulating	   endosomal	   vesicle	  trafficking.	   Fibroblast	   from	   MLIV	   patients	   showed	   a	   defect	   in	   delivering	  internalized	   materials	   to	   the	   final	   target	   (27);	   increased	   number	   of	  autophagosomes	   were	   observed	   in	   TRPML1	   deficient	   cells,	   indicating	   a	  requirement	  of	  Ca2+	  release	  in	  vesicle	  fusion	  (28);	  in	  the	  overexpression	  system,	  a	  gain-­‐of-­‐function	  mutant	  of	  TRPML1	  targets	  to	  plasma	  membrane	  substantially	  (29),	  suggesting	  that	  TRPML1	  activation	  is	  involved	  in	  vesicle	  exocytosis.	   	   	   	   	   	  	  Pigmentation	  of	   fur	   and	  hair	   is	   achieved	  by	   the	   exocytosis	  of	  melanosomes.	  A	  gain-­‐of-­‐function	  mutant	  of	  TRPML3	   leads	   to	   incomplete	  pigmentation	   in	  mice,	  suggesting	   a	   role	   of	   TRPML3	   in	   membrane	   trafficking.	   By	   overexpressing	   or	  knocking	   down	   TRPML3,	   Kim	   et	   al.	   showed	   that	   TRPML3	   overexpression	  inhibited	   endocytosis	   and	   knocking	   down	   TRPML3	   produced	   a	   reciprocal	  results,	  as	  illustrated	  by	  results	  obtained	  from	  several	  independent	  endocytosis	  assays,	   including	   transferrin	   uptake,	   EGF	   uptake	   and	   EGFR	   degradation	   (30).	  These	   findings	  were	  confirmed	  by	  results	   from	  another	  group,	  who	  conducted	  the	   study	   at	   approximately	   the	   same	   time	   (31).	   Together,	   studies	   of	   cells	  bearing	   TRPML3	   mutations	   revealed	   more	   autophagy	   initiation	   events,	   but	  delayed	  autolysosome	  maturation,	  indicating	  a	  role	  of	  TRPML3	  in	  the	  fusion	  of	  lysosome	  and	  autophagosome	  (30,	  31).	   	  
1.5	  Significance	  
	   Constant	   trafficking	   is	   one	   of	   the	   fundamental	   features	   of	   endolysosomal	  vesicles	   and	   important	   for	   lysosomes	   to	   carry	   out	   the	   degradation	   function.	  TRPML	   channels	   play	   critical	   roles	   in	   endolysosome	   trafficking	   and	   as	   an	  integral	  part	  of	  their	  functioning,	  they	  appear	  at	  the	  corresponding	  subcellular	  localizations.	   Therefore,	   the	   mechanism	   of	   regulation	   of	   TRPML	   channel	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Chapter	  2	  Methods	  and	  Materials	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2.1	  Cell	  Culture	  and	  Transfection	  
	   HEK293	  cells	  were	  cultured	  in	  Dulbecco's	  minimal	  essential	  medium	  containing	  4.5	  mg/ml	  glucose,	  10%	  fetal	  bovine	  serum,	  50	  units/ml	  penicillin,	  and	  50	  μg/ml	  streptomycin	  in	  the	  incubator	  at	  37	  °C	  and	  5%	  CO2,	  as	  previously	  described	  (32).	   	  	  For	  confocal	  imaging,	  transfection	  was	  done	  as	  follow:	  cells	  were	  grown	  in	  wells	  of	  a	  6-­‐well	  plate	  to	  40-­‐60%	  confluence;	  100	  ng	  of	  the	  desired	  plasmids	  were	  added	  to	  100	  µl	  0.15	  M	  NaCl	  solution,	  which	  was	  then	  mixed	  with	  8	  µl	  of	  25	  mM	  polyethylenimine	  (PEI).	  After	  a	  brief	  mixing	  by	  vortex,	  the	  mixture	  was	  left	  at	  room	  temperature	  for	  10	  min	  to	  allow	  the	  formation	  of	  PEI-­‐DNA	  complexes.	  The	  mixed	  solution	  was	  then	  added	  drop-­‐by-­‐drop	  to	  the	  well	  and	  the	  plate	  was	  gently	  shaken	  in	  order	  to	  evenly	  distribute	  the	  transfection	  complex	  into	  the	  medium.	  For	  all	  other	  experiments,	  transfection	  was	  performed	  in	  the	  same	  way	  except	  that	  the	  amount	  of	  DNA	  was	  increased	  to	  1	  µg.	   	  	  
2.2	  Plasmids	  and	  cloning	   	  
	   TRPML1-­‐EGFP	  was	  created	  by	  PCR	  amplification	  of	  the	  coding	  sequence	  of	  mouse	  TRPML1	  and	  fusing	  the	  purified	  DNA	  fragment	  with	  the	  pEGFP-­‐N1	  vector	  (Clontech)	  using	  the	  In-­‐Fusion	  PCR	  Cloning	  System	  (Clontech).	  MCherry–TRPML3	  was	  created	  by	  PCR	  amplification	  of	  the	  coding	  sequence	  of	  mouse	  TRPML3	  and	  fusing	  the	  purified	  DNA	  fragment	  with	  the	  pmCherry-­‐C1	  vector	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(Clontech).	  TRPML3-­‐KK	  mutant	  was	  created	  following	  the	  protocol	  outlined	  in	  the	  QuikChange	  Site-­‐Directed	  Mutagenesis	  kit	  (Stratagene).	  pGCaMPN1	  was	  created	  by	  swapping	  the	  coding	  sequence	  of	  EGFP	  in	  pEGFPN1	  with	  that	  of	  GCaMP5G	  (33).	  LAMP1-­‐GCaMP5G	  and	  TRPML1-­‐GCaMP5G	  were	  generated	  by	  fusing	  the	  LAMP1	  or	  TRPML1	  coding	  sequence,	  amplified	  by	  PCR,	  with	  the	  pGCaMPN1	  vector.	  TRPML1-­‐KK,	  TRPML1-­‐Va,	  TRPML1-­‐7Q,	  TRPML1-­‐4A	  (all	  mouse	  sequences)	  were	  generous	  gifts	  from	  Dr.	  Haoxing	  Xu	  (University	  of	  Michigan).	  Plasmid	  preparations	  were	  performed	  using	  the	  Qiaprep	  Spin	  Miniprep	  Kit	  (Qiagen).	  	  
2.3	  Fluorescence	  imaging	  
At	   approximately	   16	   hrs	   post	   transfection,	   cells	   were	   subcultured	   at	   the	  confluence	   of	   20%-­‐30%	   to	   15-­‐mm	   round	   glass	   coverslip	   (Fisher	   Scientific)	  coated	   with	   poly-­‐L-­‐ornithine	   (20	   µg/ml	   in	   sterile	   H2O,	   Sigma)	   and	   grown	  overnight.	   For	   immunocytochemical-­‐staining,	   cells	   were	   fixed	   in	   4%	  paraformaldehyde	  (PFA)	  in	  PBS	  at	  the	  room	  temperature	  for	  20	  minutes,	  then	  permeablized	  and	  blocked	  in	  PBS	  containing	  0.1%	  saponin	  and	  5%	  non-­‐fat	  milk	  for	  1	  hrs.	  Primary	  antibody	  was	  diluted	  at	  1:1000	  in	  PBS	  containing	  1%	  non-­‐fat	  milk	  and	  added	  to	  the	  cells	  to	  allow	  incubation	  at	  4	  °C	  overnight.	  Then	  the	  cells	  were	  washed	  three	  times	  with	  PBS	  for	  5	  minutes	  each.	  Secondary	  antibody	  was	  diluted	  at	  1:1000	   in	  PBS	  containing	  1%	  non-­‐fat	  milk	  and	  added	   to	   the	  cells	   to	  allow	  incubation	  at	  room	  temperature	  for	  60	  mins.	  This	  was	  followed	  by	  three	  5-­‐minute	  washes	  with	  PBS.	  After	  staining,	  the	  coverslip	  was	  mounted	  on	  a	  glass	  microscopy	  slide	  using	  FluoroGel	  mount	  media	  (Electron	  Microscopy	  Sciences)	  and	  left	  at	  the	  room	  temperature	  overnight.	  For	  long-­‐term	  preservation,	  slides	  were	  kept	  at	  -­‐20°C.	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  The	   mouse	   monoclonal	   anti-­‐LAMP2	   antibody	   was	   obtained	   from	   the	  Developmental	   Studies	   Hybridoma	   Bank	   (University	   of	   Iowa);	   the	   anti-­‐GFP	  antibody	  was	  purchased	  from	  Life	  Technologies;	  the	  anti-­‐mCherry	  antibody	  was	  from	   Bio-­‐Vision.	   All	   confocal	   fluorescence	   images	   were	   taken	   with	   a	   Nikon	  eclipse	   Ti	   laser	   scanning	   confocal	   microscope	   system,	   using	   the	   software	  NIS-­‐viewer.	   	  	  Pearson’s	  colocalization	  analysis	  was	  performed	  using	  Fiji	  (image	  J)	  (34).	  	  
2.4	  Intracellular	  Ca2+	  concentration	  measurement	  
	   Non-­‐transfected	   or	   transfected	   cells	   were	   seeded	   to	   the	   center	   of	   a	   25-­‐mm	  round	   glass	   coverslip	   (Fisher	   Scientific)	   coated	   with	   poly-­‐L-­‐ornithine	   at	   a	  density	   of	   ~20%	   and	   grown	   overnight.	   Cells	   were	   loaded	   with	   1	   µg/ml	  Fura2-­‐AM	  for	  30	  min	  at	  37	  °C	  in	  DMEM	  after	  washing	  with	  HBSS	  3	  times.	  After	  loading,	  the	  cells	  were	  rinsed	  in	  extracellular	  solution	  (140	  mM	  NaCl,	  5	  mM	  KCl,	  1	  mM	  MgCl2,	  10	  mM	  glucose,	   and	  10	  mM	  HEPES,	  pH	  7.4)	   three	   times	  and	   the	  coverslip	  mounted	  in	  a	  recording	  chamber	  placed	  on	  the	  stage	  of	  a	  Nikon	  TE200	  inverted	   fluorescence	   microscope.	   Intracellular	   Ca2+	   concentration	   changes	  were	   monitored	   using	   the	   InCytIm2	   Imaging	   System	   (Intracellular	   Imaging),	  with	   alternating	  excitations	  at	  340	  and	  380	  nm	  every	   second	  and	  emission	  of	  515	  nm.	  The	  340/380	  ratios	  of	   individual	  regions	  of	   interest	  were	  determined	  on-­‐line	   and	   converted	   to	   Ca2+	   concentration	   using	   a	   calibration	   curve	  established	   under	   the	   same	   microscope	   and	   camera	   settings.	   For	   cells	  transfected	   with	   a	   GCaMP-­‐containing	   construct,	   the	   Ca2+	   measurement	   was	  performed	  without	  Fura2	  loading	  and	  with	  the	  use	  of	  a	  470	  nm	  excitation	  filter	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and	   	   InCytIm1	   software.	   Relative	   fluorescence	   intensities	   were	   used	   for	  quantification.	   The	   nominally	   calcium	   free	   extracellular	   buffer	   contained	   140	  mM	  NaCl,	   5	  mM	  KCl,	   1	  mM	  MgCl2,	   10	  mM	  glucose,	  15	  mM	  HEPES,	  pH7.4.	  The	  normal	   calcium-­‐containing	   extracellular	   buffer	   was	   made	   by	   including	   2	   mM	  CaCl2	  in	  the	  nominally	  calcium	  free	  extracellular	  buffer.	  	  
2.5	  Cell-­‐surface	  biotinylation	  assay	  and	  western	  blot	  
	   Two	  days	  after	  transfection,	  cells	  in	  6-­‐well	  plates	  were	  chilled	  on	  ice-­‐water	  slurry	  for	  5	  min	  and	  then	  washed	  three	  times	  with	  ice-­‐cold	  PBS.	  The	  chilled	  cells	  were	  incubated	  on	  ice	  with	  1	  ml	  freshly	  made	  PBS	  containing	  0.5	  mg/ml	  Sulfo-­‐NHS-­‐	  LC-­‐biotin	  (Pierce)	  for	  30	  min	  to	  allow	  thorough	  biotin	  labeling.	  At	  the	  end	  of	  incubation,	  the	  labeling	  reaction	  was	  quenched	  by	  the	  addition	  of	  1	  ml	  100	  mM	  glycine	  and	  the	  cells	  washed	  three	  times	  with	  ice-­‐cold	  PBS	  containing	  100	  mM	  glycine.	  Cells	  were	  then	  harvested	  with	  the	  use	  of	  a	  rubber	  policeman	  and	  collected	  in	  a	  1.5-­‐ml	  centrifuge	  tube,	  which	  was	  followed	  by	  5	  min	  centrifugation	  at	  5,000xg	  in	  a	  pre-­‐chilled	  motor	  at	  4°C.	  Supernatant	  was	  aspirated	  and	  100	  µl	  RIPA	  buffer	  (10	  mM	  Tris-­‐Cl,	  1%	  Triton	  X-­‐100,	  0.1%	  sodium	  deoxycholate,	  0.1%	  SDS,	  140	  mM	  NaCl,	  pH	  8.0)	  supplemented	  with	  protease	  inhibitors	  (Sigma)	  were	  added	  to	  the	  cell	  pellet.	  This	  was	  followed	  by	  sonication	  to	  disrupt	  the	  cells	  and	  then	  85	  µl	  of	  the	  cell	  lysate	  were	  transferred	  to	  a	  new	  1.5-­‐ml	  centrifuge	  tube	  containing	  a	  slurry	  of	  20	  µl	  avidin-­‐beads	  (Pierce).	  The	  cell	  lysate	  was	  incubated	  with	  the	  avidin-­‐beads	  for	  2	  hrs	  on	  a	  rotating	  shaker	  at	  4	  °C	  before	  being	  centrifuged	  for	  5	  min	  at	  5,000xg.	  The	  supernatant	  was	  removed	  and	  beads	  were	  washed	  three	  times	  with	  the	  RIPA	  buffer,	  with	  centrifugation	  at	  5,000xg	  for	  5	  min	  between	  washes.	  After	  washing,	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the	  beads	  were	  incubated	  with	  10	  µl	  of	  a	  2X	  SDS	  loading	  buffer	  (1X	  =62.5	  Tris-­‐Cl,	  1%	  SDS,	  10%	  glycerol,	  10%	  β-­‐mercaptoethanol,	  pH	  6.8)	  at	  the	  room	  temperature	  for	  30	  min	  to	  elute	  the	  bound	  proteins.	  Aliquots	  of	  elutes	  from	  avidin	  beads	  and	  crude	  lysates	  were	  subjected	  to	  SDS-­‐PAGE	  and	  western	  blotting	  using	  an	  anti-­‐mCherry	  antibody	  (1:2000),	  which	  was	  followed	  by	  a	  DyLight	  680	  conjugated	  goat	  anti-­‐rabbit	  IgG	  secondary	  antibody	  (1:2000).	  Detection	  of	  antibody	  labeling	  on	  the	  blots	  was	  performed	  using	  the	  Odyssey	  Imaging	  system	  (LI-­‐COR	  Biosciences).	   	  
	  
2.6	  Statistics	  







Chapter	   3	   Subcellular	   localizations	   of	  
TRPML1	   and	   TRPML3	   to	   lysosomes	   are	  
dependent	   on	   targeting	   sequence	   and	  








3.2.1	   Intracellular	   calcium	   imaging	   reveals	   TRPML1-­‐KK	   and	  
TRPML3-­‐KK	  as	  non-­‐functional	  mutants.	   	  
	   	  
Zeevi	   et	   al.	   (26)	   suggested	  TRPML3-­‐DD458/459KK,	   or	  TRPML3-­‐KK,	   to	   be	   a	   dominant	  negative	  mutant	  based	  on	  the	  evidence	  that	  in	  whole	  cell	  patch	  clamp	  recordings	  when	  TRPML3-­‐KK	  was	  co-­‐expressed	  with	  a	  plasma	  membrane-­‐localized	  constitutively	  active	  TRPML1	  mutant,	  the	  current	  density	  of	  TRPML1	  was	  significantly	  reduced.	  However,	  it	  remained	   unknown	   whether	   this	   was	   due	   to	   the	   reduced	   expression	   of	   plasma	  membrane	   localized	   gain-­‐of-­‐function	  TRPML1	  mutant	   or	   the	  dominant-­‐negative	   effect	  of	   TRPML3-­‐KK.	   Indeed,	   no	   direct	   evidence	   had	   ever	   shown	   that	   TRPML3-­‐KK	  was	   not	  conductive.	  The	  recent	  identification	  of	  membrane	  permeable	  synthetic	  TRPML	  agonist,	  ML-­‐SA1	  (36),	  offered	  a	  new	  opportunity	  to	  test	  the	  function	  of	  TRPML3-­‐KK	  by	  standard	  Ca2+	   imaging	   method	   that	   measures	   real	   time	   changes	   in	   intracellular	   calcium	  concentrations.	  To	  do	  this,	  HEK293	  cells	  transiently	  transfected	  with	  wild	  type	  TRPML3	  or	   TRPML3-­‐KK	   were	   loaded	   with	   Fura2	   and	   monitored	   by	   Ca2+	   imaging.	   Upon	  application	  of	  ML-­‐SA1	  (20	  µM),	  the	  intracellular	  Ca2+	  concentration	  increased	  by	  458.3	  ±	  89.7	   nM	   (n	   =	   22)	   in	   cells	   that	   expressed	  wild	   type	   TRPML3	   (Fig.	   1).	   By	   contrast,	   the	  intracellular	   Ca2+	   concentration	   barely	   changed	   in	   response	   to	   ML-­‐SA1	   in	   cells	   that	  expressed	  TRPML3-­‐KK	  (13.2	  ±	  1.3	  nM,	  n	  =	  17).	  This	  suggested	  that	  TRPML3-­‐KK	  was	  not	  functional.	   	  	   TRPML1-­‐KK	  was	  shown	  to	  be	  a	  dominant-­‐negative	  mutant	  in	  the	  same	  previous	  study	  (26),	   while	   direct	   evidence	   showing	   that	   TRPML1-­‐KK	   was	   non-­‐conductive	   was	   also	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lacking.	   Therefore,	   I	   also	   tested	   TRPML1-­‐KK	   using	   ML-­‐SA1.	   In	   a	   nominally	   Ca2+-­‐free	  extracellular	  solution,	  20	  µM	  ML-­‐SA1	  induced	  an	  intracellular	  Ca2+	  concentration	  rise	  by	  120.2	  ±	  19.8	  nM	  in	  cells	  that	  co-­‐expressed	  wild	  type	  TRPML1	  and	  TRPML3.	  This	  differed	  drastically	  from	  cells	  that	  co-­‐expressed	  TRPML1-­‐KK	  and	  wild	  type	  TRPML3,	  which	  was	  little	  affected	  by	  ML-­‐SA1	  (The	  measured	  change	  was	  19.4	  ±	  4.9	  nM).	   	  	  Consistent	   with	   the	   previous	   finding	   that	   expression	   of	   TRPML1	   reduced	   plasma	  membrane	  localization	  of	  TRPML3,	  in	  an	  extracellular	  solution	  that	  contained	  2	  mM	  Ca2+,	  cells	   co-­‐expressing	   wild	   type	   TRPML1	   and	   wild	   type	   TRPML3	   showed	   a	   decreased	  calcium	   response	   (129.1	   ±	   31.1nM),	   compared	   to	   cells	   expressing	   only	   TRPML3.	  Interestingly,	   the	  ML-­‐SA1-­‐evoked	   intracellular	  Ca2+	   rise	  was	  not	   significantly	  different	  between	   cells	   assayed	   in	   the	   nominally	   Ca2+-­‐free	   and	   Ca2+-­‐containing	   extracellular	  solutions	  (Fig.	  1),	  suggesting	  that	  with	  the	  coexpression	  of	  TRPML1	  and	  TRPML3,	  most	  Ca2+	   increases	   elicited	   by	   the	   TRPML	   agonist	   arose	   from	   internal	   Ca2+	   release	   rather	  than	  Ca2+	   influx	   from	  extracellular	   space.	   Surprisingly,	  no	  detectable	   intracellular	  Ca2+	  increase	   was	   seen	   in	   TRPML1-­‐transfected	   cells	   or	   non-­‐transfected	   cells	   with	   the	  application	   of	   ML-­‐SA1,	   indicating	   that	   TRPML1	   was	   not	   activated	   by	   the	   compound	  under	  our	  experimental	  condition.	  Therefore,	  the	  detected	  Ca2+	  increase	  in	  TRPML1	  and	  TRPML3	  co-­‐expressing	   cells	   likely	   represented	   the	  activation	  of	  TRPML3.	   In	   this	   case,	  TRPML3	  either	  worked	  as	  homomers	  or	  heteromers	  with	  TRPML1.	  The	  finding	  that	  the	  Ca2+	   signals	   were	   mainly	   generated	   from	   internal	   Ca2+	   release	   suggests	   that	   the	  intracellularly	   localized	   TRPML3	   was	   accessible	   by	   the	   bath	   applied	   membrane	  permeable	   ML-­‐SA1.	   Therefore,	   the	   lack	   of	   effect	   of	   the	   TRPML	   agonist	   on	  TRPML1-­‐expressing	   cells	   was	   unlikely	   due	   to	   its	   inaccessibility	   to	   intracellular	  compartments..	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   3.2.2	   TRPML1-­‐KK	   and	   TRPML3-­‐KK	   had	   distinct	   subcellular	  
localization,	  comparing	  to	  wildtype	  TRPML1	  and	  TRPML3	  
	   In	   the	   effort	   to	   characterize	   the	   ionic	   current	   mediated	   by	   the	   dominant-­‐negative	  TRPML1	  mutant,	  TRPML1-­‐KK,	  I	  noticed	  that	  the	  EGFP	  tagged	  TRPML1-­‐KK	  did	  not	  show	  up	   in	   the	   membrane	   of	   enlarged	   vesicles	   induced	   by	   the	   treatment	   of	   vacuolin-­‐1	   in	  HEK293	  cells	  (picture	  not	  shown).	  Therefore,	  I	  used	  confocal	  microscopy	  to	  examine	  the	  subcellular	   localization	   of	   TRPML1-­‐KK.	   In	   sharp	   contrast	   with	   the	   lysosome-­‐targeted	  wild	   type	  TRPML1,	   the	  non-­‐functional	  TRPML1-­‐KK	  was	   retained	   in	   the	  ER,	   showing	  a	  high	  degree	  of	   colocalization	  with	  STIM1,	   an	  ER-­‐localized	  membrane	  protein	   (Fig.	  2A,	  2E).	   	  	  The	  fact	  that	  the	  non-­‐functional	  TRPML1	  mutant	  was	  retained	  in	  the	  ER	  brought	  up	  the	  question	   whether	   the	   channel	   function	   regulates	   the	   exit	   of	   TRPML1	   from	   the	   ER	   to	  lysosome.	   I	   therefore	   generated	   another	   previously	   reported	   dominant-­‐negative	  TRPML1	  mutant,	   TRPML1-­‐F465L	   (26).	   Upon	   examination	   of	   its	   subcellular	   location,	   I	  found	   that	   this	   mutant	   was	   almost	   exclusively	   localized	   to	   lysosomes	   (Fig.	   2B),	   in	   a	  similar	   pattern	   as	   the	  wild	   type	   TRPML1	   (Fig.	   2D).	   This	   suggests	   that	   it	   was	   not	   the	  channel	   function	   but	   the	   two	   consecutive	   aspartic	   acids	   that	   determine	   whether	  TRPML1	  could	  be	  trafficked	  out	  of	  the	  ER.	   	  	  TRPML1	  and	  TRPML3	  share	  high	  amino	  acid	  sequence	  similarity,	  especially	  in	  the	  pore	  area.	  I	  therefore	  examined	  whether	  the	  two	  aspartic	  acids	  in	  the	  conserved	  positions	  of	  TRPML3	  were	  also	  important	  for	  trafficking	  out	  of	  the	  ER.	  Using	  confocal	  microscopy	  to	  examine	  the	  subcellular	   location	  of	  TRPML3-­‐KK,	   I	   found	  it	  also	  retained	  in	  the	  ER	  and	  highly	   co-­‐localized	   with	   STIM1	   (Fig.	   2C,	   2E).	   As	   controls,	   in	   parallel	   transfections,	  wild-­‐type	   TRPML1	   showed	   a	   typical	   lysosome	   localization	   while	   wild	   type	   TRPML3	  
	  20	  
appeared	  to	  be	  associated	  with	  both	  plasma	  membrane	  and	  lysosomes.	  	  
	  	  Fig.	   2.	   Confocal	   Microscopy	   Analysis	   of	   Subcellular	   Localization	   of	   TRPML-­‐KK.	   A)	  HEK293	  cells	  co-­‐transfected	  with	  TRPML1-­‐KK	  and	  STIM1;	  B)	  HEK293	  cells	  transfected	  with	  TRPML1-­‐F465L	  and	  immunostained	  with	  LAMP2;	  C)	  HEK293	  cells	  co-­‐transfected	  with	   TRPML3-­‐KK	   and	   STIM1;	   D)	   HEK293	   cells	   transfected	   with	   TRPML1-­‐wt	   or	  TRPML3-­‐wt;	  E)	  Pearson’s	   colocalization	   index	  analysis	  of	  TRPML-­‐KK	  and	  STIM1.	  Data	  represent	   the	   mean	  ±	   SEM.	   Scale	   bar	   represents	   10	   μm.	   Scale	   is	   the	   same	   for	   all	  images.	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3.2.3	  Heteromultimeric	  channels	  formed	  by	  TRPML1-­‐KK/	  
TRPML3	  or	  TRPML1/TRPML3-­‐KK	  are	  targeted	  to	  lysosomes	  
	  It	  was	  shown	  that	  TRPML3	  subcellular	  localization	  followed	  that	  of	  TRPML1,	  based	  on	  the	   result	   that	  TRPML1	   facilitated	   targeting	  of	  TRPML3	   to	   lysosomes	   (18).	  The	  newly	  generated	   TRPML1	   mutants	   provided	   the	   opportunity	   to	   examine	   whether	   this	  hierarchy	  was	   due	   to	   TRPML1	   channel	   function	   or	   targeting	   sequences	   that	   reside	   in	  TRPML1.	   	  	   If	  TRPML1	  were	  the	  determining	  factor,	  channels	  formed	  by	  TRPML1-­‐KK	  and	  TRPML3	  should	  be	  retained	  in	  the	  ER.	  However,	  when	  TRPML1-­‐KK	  and	  wild	  type	  TRPML3	  were	  co-­‐expressed,	  TRPML1-­‐KK,	  presumably	  in	  complexes	  with	  TRPML3	  as	  heteromultimeric	  channels,	  was	  successfully	  targeted	  to	  the	  lysosomes	  (Fig.	  3C).	  This	  argued	  against	  the	  dominant	   role	   of	   TRPML1	   in	   determining	   the	   subcellular	   localization	   of	   the	  TRPML1-­‐TRPML3	  complexes.	  As	  a	  control,	  I	  also	  co-­‐transfected	  wild	  type	  TRPML1	  with	  TRPML3-­‐KK	  (Fig.	  3A)	  and	  found	  TRPML3-­‐KK	  to	  be	  able	  to	  traffic	  to	  lysosomes	  with	  the	  coexistence	  of	  wild	  type	  TRPML1.	  By	  contrast,	  when	  TRPML1-­‐KK	  and	  TRPML3-­‐KK	  were	  co-­‐expressed,	   both	   proteins	   were	   retained	   in	   the	   ER,	   similar	   to	   the	   expression	   of	  TRPML1-­‐KK	   or	   TRPML3-­‐KK	   alone.	   These	   results	   suggest	   that	   the	   two	   conserved	  aspartic	  acids	  are	  critical	  for	  the	  export	  of	  TRPML	  proteins	  out	  of	  the	  ER.	  	  There	  are	  17	  predicted	  glycosylation	  sites	   in	  the	  extracellular	  domains	  of	  the	  TRPML3	  protein.	   Since	   protein	   glycosylation	   is	   completed	   after	   trafficking	   through	   Golgi	  apparatus,	   the	   ER-­‐retained	   TRPML3	   should	   have	   an	   altered	   glycosylation	   pattern	   as	  compared	  to	  the	  wild	  type	  protein,	  which	  would	  result	  in	  a	  different	  migration	  rate	  on	  the	   SDS-­‐PAGE.	   Indeed,	   the	   heterologously	   expressed	   mCherry-­‐TRPML3	   showed	  multiple	   bands	   on	   western	   blots,	   presumably	   representing	   different	   stages	   of	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glycosylation	  at	   its	  biosynthetic	  pathway.	  When	  expressed	  alone	  or	  co-­‐expressed	  with	  the	   similarly	   ER-­‐retained	   TRPML1-­‐KK,	   the	   TRPML3-­‐KK	   mutant	   lacked	   the	   high	  molecular	  weight	  bands,	  consistent	  with	   the	  notion	  that	   it	  was	  retained	   in	   the	  ER	  and	  therefore	   incompletely	   glycosylated.	   On	   the	   other	   hand,	   when	   coexpressed	  with	  wild	  type	   TRPML1,	   TRPML3-­‐KK	   showed	   similar	  migration	   pattern	   on	   the	   blot	   as	   the	  wild	  type	  TRPML3,	  suggesting	  a	  more	  complete	  glycosylation.	  To	  verify	  that	  the	  upper	  bands	  represent	  glycosylated	  mCherry-­‐TRPML3,	  I	  treated	  the	  cell	  lysates	  with	  PNGaseF,	  which	  cleaves	  sugar	  residues	  from	  proteins.	  As	  expected,	  the	  treatment	  of	  PNGaseF	  reduced	  all	  the	  bands	  to	  the	  equal	  molecule	  size	  (Fig.	  3F)	   	  	  The	   TRPML1-­‐4A	   mutant	   is	   preferentially	   targeted	   to	   plasma	   membrane.	   To	   examine	  whether	  TRPML1	  determines	  the	  localization	  of	  TRPML3,	  TRPML1-­‐4A	  was	  coexpressed	  with	  wild	  type	  TRPML3	  and	  shown	  to	  be	  co-­‐localized	  on	  the	  PM	  (Fig.	  3E).	  	  Taken	   together,	   the	   above	   data	   suggest	   that	   the	   two	   aspartic	   acids,	   DD471/472	   in	  TRPML1	  and	  DD458/459	  in	  TRPML3,	  represent	  the	  targeting	  sequence	  for	  TRPMLs	  to	  be	  trafficked	  out	  of	  the	  ER.	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TRPML1-­‐wt TRPML3-­‐wt LAMP2 Merge 
TRPML1-­‐wt TRPML3-­‐KK LAMP2 Merge 
TRPML1-­‐KK TRPML3-­‐wt LAMP2 Merge 
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Fig.	   3.	   Confocal	   Microscopy	   Analysis	   of	   Subcellular	   Localization	   of	   TRPML-­‐wt/KK	  Co-­‐transfection.	  A)	  HEK293	  cells	  co-­‐transfected	  with	  TRPML1-­‐wt	  and	  TRPML3-­‐wt	  and	  immunostained	   with	   LAMP2.	   B)	   HEK293	   cells	   co-­‐transfected	   with	   TRPML1-­‐wt	   and	  TRPML3-­‐KK	   and	   immunostained	   with	   LAMP2.	   C)	   HEK293	   cells	   co-­‐transfected	   with	  TRPML1-­‐KK	   and	   TRPML3-­‐wt	   and	   immunostained	   with	   LAMP2.	   D)	   HEK293	   cells	  co-­‐transfected	  with	  TRPML1-­‐KK	  and	  TRPML3-­‐KK	  and	   immunostained	  with	  LAMP2.	  E)	  HEK293	   cells	   co-­‐transfected	   with	   TRPML1-­‐4A	   and	   TRPML3-­‐wt.	   F)	   Representative	  western	   blot	   analysis	   of	   total	   lysates	   from	   HEK293	   cells	   overexpressing	   different	  combinations	  of	  TRPML	  channels;	  cell	  lysates	  were	  either	  untreated	  (upper)	  or	  treated	  with	   PNGase	   F	   (lower)	   and	   membrane	   were	   blotted	   with	   anti-­‐mCherry	   antibody.	   G)	  Pearson’s	   colocalization	   analysis	   of	   TRPML	   with	   LAMP2-­‐cy5.	   Data	   represent	   mean	   ±	  SEM.	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3.2.4	   Di-­‐leucine	   motifs	   in	   TRPML1	   facilitate	   TRPML3	  
endocytosis.	  
The	   resolution	   limit	   of	   confocal	  microscopy	  held	  me	   from	  accurately	  quantifying	  how	  effective	  TRPML1	  and	  its	  mutants	  could	  direct	  TRPML3	  to	  intracellular	  compartments.	   	  Therefore,	  I	  used	  a	  cell	  surface	  biotinylation	  assay	  to	  measure	  the	  relative	  abundance	  of	  plasma	   membrane	   localized	   TRPML3	   when	   expressed	   alone	   or	   co-­‐expressed	   with	  TRPML1	   and	   its	   mutants	   (Fig.	   4).	   The	   results	   showed	   that	   the	   coexpression	   of	  TRPML1-­‐wt,	   TRPML1-­‐F465L,	   and	   TRPML1-­‐KK,	   as	   well	   as	   TRPML1-­‐7Q	   (Fig.	   5,	   6D),	  which	   is	   insensitive	   to	   the	   endogenous	   activator,	   PI(3,5)P2,	   significantly	   reduced	   the	  surface	   expression	   of	   TRPML3,	   while	   TRPML1-­‐4A	   and	   TRPML1-­‐Va,	   the	   constitutively	  active	  TRPML1	  mutant,	  did	  not.	  Given	  that	  the	  lysosomal	  targeted	  TRPML1-­‐F465L	  and	  TRPML1-­‐7Q	   mutants	   have	   no	   or	   reduced	   channel	   activity	   and	   the	   PM-­‐localized	  TRPML1-­‐4A	   and	   TRPML1-­‐Va	   are	   either	   functionally	   normal	   or	   with	   dramatically	  increased	  basal	  activity,	  the	  above	  results	  suggest	  that	  the	  functionality	  of	  TRPML1	  may	  not	   be	   the	   only	   determining	   factor	   for	   the	   lysosome	   localization	   of	   TRPML1	   and	   the	  TRPML1-­‐TRPML3	  complexes.	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  Fig.	  4.	  Topology	  and	  functionality	  features	  of	  TRPML1	  mutants.	   	  	  





























































	   	   Previous	  studies	  suggested	   that	  TRPML3	  trafficking	  depended	  on	  TRPML1,	  suggesting	  the	  existence	  of	  a	  hierarchy	  for	  the	  subcellular	  localization	  of	  TRPML	  channels	  (18,	  26).	  In	  this	  study,	  we	  tested	  this	  idea	  by	  introducing	  mutations	  in	  TRPML1	  and	  TRPML3	  that	  altered	   subcellular	   localizations.	   The	   surface	   biotinylation	   experiments	   suggest	   that	  indeed	  TRPML3	  appeared	  to	  follow	  the	  trafficking	  of	  TRPML1,	  irrespective	  of	  TRPML1	  function.	  Therefore,	   the	  hierarchy	   theory	   could	   largely	   explain	   the	  data.	  However,	   the	  ER-­‐retained	  TRPML1-­‐KK	  was	   brought	   to	   lysosomes	   by	   co-­‐transfection	  with	  wild	   type	  TRPML3,	  suggesting	  that	  the	  hierarchy	  is	  not	  absolute.	  It	  would	  seem	  that	  the	  dominant	  effect	   of	   TRPML1	   on	   subcellular	   localization	   of	   the	   TRPML1-­‐TRPML3	   complexes	   only	  occur	  after	  the	  assembled	  heteromultimeric	  channels	  are	  exported	  from	  the	  ER.	  The	  fact	  that	  a	  wild	  type	  TRPML	  subtype	  can	  bring	  the	  ER-­‐retained	  TRPML	  mutant	  of	  a	  different	  subtype	  out	  of	  ER	  suggests	  that	  channel	  assembly	  occurs	  in	  the	  ER	  and	  in	  order	  to	  traffic	  out	  of	  the	  ER,	  not	  all	  four	  subunits	  of	  the	  channel	  need	  to	  contain	  the	  ER	  exporting	  signal	  (the	  two	  aspartic	  acids).	  Alternatively,	  instead	  of	  serving	  as	  an	  ER	  exporting	  signal,	  the	  mutations	   of	  D471	   and	  D472	   to	   lysines	   caused	  misfolding	   of	   the	  TRPML-­‐KK	  mutants,	  which	   prevented	   the	   protein	   from	   ER	   exporting.	   This	   would	   be	   consistent	   with	   the	  previous	  suggestion	  that	  TRPML1-­‐KK	  is	  a	  non-­‐functional	  pore	  mutant	  (36,	  37).	  However,	  in	  contrast	  to	  my	  findings,	  neither	  study	  indicated	  that	  TRPML1-­‐KK	  was	  retained	  in	  the	  ER.	   In	  a	   separate	   study,	  TRPML3Va-­‐KK	  was	   shown	   to	  be	  mislocalized	  as	   compared	   to	  wild	  type	  TRPML3.	  It	  is	  quite	  possible	  that	  the	  predominant	  location	  for	  this	  mutant	  is	  also	  the	  ER,	  but	  the	  authors	  did	  not	  determine	  its	  precise	  location	  (21).	  I	  have	  found	  that	  both	  TRPML1-­‐KK	  and	  TRPML3-­‐KK	  when	  expressed	  alone	  are	   retained	   in	   the	  ER.	  This	  cannot	   be	   a	   coincidence.	   It	   indicates	   that	   under	   our	   experimental	   conditions,	   the	  so-­‐called	  “pore	  dead”	  mutants	  are	  also	  trafficking	  defective	  for	  exporting	  out	  of	  the	  ER.	  If	  misfolding	  is	  the	  main	  reason	  for	  this	  defect,	  then	  the	  inclusion	  of	  one,	  two,	  or	  three	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wild	  type	  subunits	  in	  the	  tetrameric	  channel	  complex	  appears	  to	  be	  able	  to	  correct	  the	  misfolding-­‐induced	  trafficking	  problem.	   	  	   If	  TRPML1	  can	  traffic	  out	  of	  the	  ER,	  then	  the	  hierarchy	  exists	  for	  TRPML1	  and	  TRPML3.	  What	   confers	   the	   dominant	   role	   of	   TRPML1	   in	   the	   trafficking	   of	   TRPML1-­‐TRPML3	  complex	   remains	   to	   be	   elucidated.	   Since	   the	   naturally	   occurring	   pore-­‐dead	  dominant-­‐negative	   mutant	   TRPML1-­‐F465L	   localized	   to	   lysosomes	   and	   directed	  TRPML3	   trafficking	   to	   intracellular	   locations	   as	   effectively	   as	   the	  wild	   type	   TRPML1,	  being	  a	  functional	  calcium	  permeable	  channel	  would	  seem	  not	  necessary	  for	  targeting	  TRPML	   heteromultimer	   channels	   to	   lysosomes.	   Dileucine	   motif	   represents	   a	   known	  targeting	  sequence	  for	  interaction	  with	  adaptor	  proteins	  AP1-­‐AP4	  (38),	  which	  facilitate	  the	   clathrin-­‐mediated	   fission	   or	   endocytosis.	   While	   there	   is	   no	   dileucine	   motif	   in	  TRPML3,	  there	  are	  two	  dileucine	  motifs	  in	  TRPML1,	  one	  in	  the	  N	  terminus	  and	  the	  other	  in	  the	  C	  terminus.	  In	  the	  TRPML1-­‐4A	  mutant,	  both	  dileucine	  motifs	  were	  disrupted	  and	  the	  mutant	  channel	  was	  retained	  on	  the	  PM.	  As	  expected,	  TRPML1-­‐4A	  did	  not	  facilitate	  TRPML3	   internalization;	   however,	   it	   did	   not	   enhance	   the	   PM	   localization	   of	   TRPML3	  either.	   These	   results	   suggest	   an	   active	   role	   of	   the	   two	   dileucine	  motifs	   in	   facilitating	  internalization	   of	   TRPML1-­‐contianing	   channels,	   including	   both	   homomeric	   TRPML1	  and	   heteromeric	   TRPML1-­‐TRPML3	   complexes.	   Because	   TRPML3	   lacks	   the	   dileucine	  motifs,	  its	  internalization	  is	  not	  as	  efficient	  as	  that	  of	  TRPML1	  unless	  when	  in	  complex	  with	  a	  TRPML1	  subunit.	  Supporting	  this	  conclusion,	  the	  TRPML1-­‐Va	  mutant	  has	  strong	  constitutive	  activity,	  but	  did	  not	  enhance	  PM	  localization	  of	  TRPML3.	  In	  fact,	  it	  tended	  to	  decrease	   the	   PM	   localization	   of	   TRPML3,	   which	   did	   not	   reach	   statistical	   significance	  because	   of	   the	   large	   fluctuations	   from	   one	   experiment	   to	   another.	   These	   fluctuations	  were	   probably	   due	   to	   cell	   death	   associated	  with	   overexpression	   of	   the	   constitutively	  active	   TRPML1-­‐Va,	   which	   led	   to	   Ca2+	   overload	   and	   disrupted	   membrane	   integrity	   in	  some	   cells.	   In	   addition,	   the	   constitutive	   channel	   activation	   also	   enhances	   TRPML1-­‐Va	  trafficking	   to	  PM,	  which	  may	  bring	  along	   the	   coexpressed	  TRPML3,	   counteracting	   the	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Chapter	   4	   Activation	   of	   TRPML1	   Promotes	  
Lysosome	  Exocytosis	   	  




	   	  	   I	   showed	   in	   the	   last	   chapter	   that	   the	   constitutively	   active	   TRPML1-­‐Va	   did	   not	  significantly	  alter	  TRPML3	  internalization	  but	  argued	  that	  the	  lack	  of	  significance	  could	  be	   due	   to,	   at	   least	   partially,	   an	   opposing	   effect	   of	   TRPML1-­‐Va	   on	   increasing	   channel	  trafficking	   to	   PM.	   This	   is	   consistent	   with	   the	   idea	   that	   TRPML1	   function	   serves	   to	  enhance	  lysosome	  exocytosis	  (21,	  39).	  	   	   	  	   Exocytosis	  happens	  in	  both	  secretory	  cells	  and	  non-­‐secretory	  cells.	  The	  well-­‐known	  ER-­‐Golgi	  network	  represents	  an	  extremely	  efficient	  and	  precise	  cellular	  mechanism	  for	  protein	  sorting.	  Beside	  this	  conventional	  secretory	  pathway,	  there	  also	  exist	  unconventional	  types	  of	  protein	  transport	  (40),	  including	  lysosome	  exocytosis.	  As	  a	  pool	  of	  intracellular	  acidic	  membrane-­‐bound	  vesicles,	  lysosome	  could	  undergo	  exocytosis	  upon	  stimulation	  by	  elevated	  intracellular	  Ca2+	  concentration,	  in	  a	  microtubule-­‐dependent	  fashion	  (41,	  42).	  Lysosome	  exocytosis	  plays	  important	  roles	  in	  multiple	  physiological	  functions,	  including	  plasma	  membrane	  repair	  (41),	  neural	  growth	  (43),	  cell	  migration	  (44).	  	  Recent	  studies	  have	  implicated	  lysosome	  exocytosis	  as	  a	  critical	  step	  in	  cellular	  clearance	  and	  this	  process	  was	  shown	  to	  be	  TRPML1-­‐dependent	  (45,	  46).	  Another	  study	  showed	  that	  in	  the	  cell	  model	  of	  Niemann-­‐Pick	  disease,	  a	  lysosomal	  storage	  disorder,	  treatment	  with	  a	  TRPML1	  agonist	  dramatically	  reduced	  the	  disease	  phenotype	  (36),	  suggesting	  a	  possible	  role	  of	  TRPML1	  function	  in	  lysosome	  exocytosis	  regulation.	  It	  was	  well	  established	  that	  increased	  intracellular	  Ca2+	  concentration	  could	  trigger	  lysosome	  exocytosis.	  However,	  in	  most	  studies,	  the	  elevation	  of	  intracellular	  Ca2+	  level	  was	  achieved	  by	  pharmacological	  tools	  that	  either	  introduce	  Ca2+	  through	  Ca2+	  influx	  from	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extracellular	  space	  or	  via	  Ca2+	  release	  from	  the	  ER.	  It	  was	  not	  known,	  however,	  if	  Ca2+	  release	  from	  lysosomes	  via	  TRPML1	  would	  initiate	  lysosome	  exocytosis.	  Here,	  by	  measuring	  the	  plasma	  membrane-­‐localized	  TRPML3	  as	  the	  functional	  readout	  of	  lysosome	  exocytosis,	  I	  examined	  the	  role	  of	  TRPML	  function	  in	  lysosome	  exocytosis.	   	  	  
4.2	  Results	  
	  
4.2.1	  TRPML1	  activation	  increased	  lysosome	  exocytosis	  
	  Induction	   of	   lysosome	   exocytosis	   includes	   the	   fusion	   of	   lysosome	   with	   plasma	  membrane,	   a	   process	   triggered	   by	   intracellular	   Ca2+	   concentration	   rise,	   to	   which	   the	  Ca2+-­‐permeable	  TRPML1	  channel	  may	  contribute.	  However,	  TRPML1	  also	  contains	   the	  dileucine	  motifs	   that	   confer	   efficient	   endocytosis	   of	   itself	   and	   its	   interaction	  partners.	  Because	   of	   this,	   endocytosis	   of	   heteromultimeric	   channels	   formed	   by	   TRPML1	   and	  TRPML3	   could	   be	   enhanced	   by	   the	   overexpression	   and/or	   functional	   activation	   of	  TRPML1,	   making	   it	   difficult	   to	   detect	   the	   role	   of	   TRPML	   channels	   on	   exocytosis.	   To	  circumvent	  the	  possibility	  that	  endocytosis	  might	  offset	  the	  lysosome	  exocytosis,	  I	  used	  dynasore	  (47),	  a	  membrane	  permeable	  inhibitor	  of	  dynamin,	  which	  is	  the	  motor	  protein	  essential	   for	   the	   major	   form	   of	   endocytosis	   in	   cells,	   to	   minimize	   plasma	   membrane	  localized	  channel	  from	  being	  internalized.	   	  	  Two	  days	  after	  cells	  were	  co-­‐transfected	  with	  TRPML1	  and	  TRPML3,	  they	  were	  treated	  with	  desired	  compounds	  for	  60	  mins,	  and	  this	  was	  followed	  by	  the	  cell-­‐surface	  protein	  biotinylation	   assay.	   Briefly,	   after	   the	   pharmacological	   treatments,	   cells	   were	   washed	  with	   ice-­‐cold	   PBS	   three	   times	   to	   wash	   out	   the	   drugs	   as	   well	   as	   to	   stop	   all	   cellular	  membrane	   trafficking.	   Then	   PBS	   containing	   0.5	   mg/ml	   biotin-­‐labeling	   reagent	   was	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added	   and	   incubated	   with	   the	   cells	   for	   30	   min	   to	   allow	   thorough	   labeling	   of	   all	   the	  plasma	   membrane	   localized	   proteins	   that	   contain	   primary	   amines,	   including	   the	  overexpressed	   mCherry-­‐TRPML3.	   I	   found	   that	   the	   activation	   of	   TRPML	   by	   ML-­‐SA1	  dramatically	  increased	  plasma	  membrane	  localized	  TRPML3	  to	  up	  to	  4-­‐folds,	  comparing	  to	   the	   vehicle	   treatment	   as	  well	   as	   the	  dynasore-­‐only	   treatment,	   indicating	   a	  massive	  lysosome	  exocytosis	  upon	  the	  TRPML	  agonist	  treatment	  (Fig.	  6A,	  6B).	  Also,	  the	  dynasore	  treatment	   alone	   caused	   an	   increase	   in	   the	   plasma	   membrane	   localized	   TRPML3,	  indicating	  that	  there	  was	  constitutive	  lysosome	  exocytosis	  in	  HEK293	  cells.	  	   	  
4.2.2	  TRPML1	  function	  did	  not	  decrease	  lysosome	  exocytosis	  
	   Confirming	  that	  TRPML	  activation	  was	  sufficient	  for	  lysosome	  exocytosis,	  I	  next	  asked	  if	  TRPML1	   function	   was	   also	   necessary	   for	   lysosome	   exocytosis.	   Using	   the	   newly	  discovered	   TRPML1	   antagonist	   ML-­‐SI1	   (39),	   I	   tested	   whether	   TRPML1	   function	   was	  necessary	   for	   the	   constitutive	   lysosome	   exocytosis.	   Unexpectedly,	   however,	   TRPML1	  inhibition	   did	   not	   affect	   the	   constitutive	   lysosome	   exocytosis;	   the	   vehicle	   treated	   and	  ML-­‐SI1	   treated	   cells	   showed	   essentially	   no	   difference	   in	   plasma	  membrane	   localized	  TRPML3,	   and	   dynasore	   treated	   cells	   showed	   no	   difference	   from	   dynasore	   +	   ML-­‐SI1	  treated	  cells	  in	  the	  level	  of	  plasma	  membrane-­‐localized	  TRPML3	  (Fig.	  6A,	  6C).	   	  	  	  To	   further	   evaluate	   the	   role	   of	   TRPML1,	   I	   also	   co-­‐transfected	   HEK293	   cells	   with	  dominant-­‐negative	  TRPML1	  mutant	  (TRPML1-­‐F465L)	  and	  TRPML3,	  and	  compared	  the	  amount	  of	  plasma	  membrane	  localized	  TRPML3	  with	  cells	  co-­‐transfected	  with	  wild	  type	  TRPML1	   and	  wild	   type	   TRPML3,	   as	  well	   as	   cells	   that	  were	   transfected	  with	   TRPML3	  only.	   I	   found	  that	   the	   introduction	  of	   the	  dominant-­‐negative	  TRPML1	  caused	  a	  similar	  reduction	   of	   plasma	  membrane	   localized	   TRPML3	   as	   the	   overexpression	   of	  wild-­‐type	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TRPML1	  (Fig.	  6D).	  These	  results	  suggest	  that	  TRPML1	  function	  is	  not	  necessary	  for	  the	  constitutive	  lysosome	  exocytosis.	  
18	  	  	  Fig.	  6.	  A)	  Representative	  western	  blot	  of	  total	  and	  plasma	  membrane	  localized	  TRPML3.	  B)-­‐D)	   Quantification	   of	   plasma	  membrane	   localized	   TRPML3.	   Data	   represent	   mean	   ±	  SEM.	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4.3	  Discussion	   	  
The	   above	   data	   indicate	   the	   existence	   of	   both	   TRPML-­‐dependent	   and	   TRPML1	  independent	  pathways	  of	  lysosome	  exocytosis	  in	  HEK293	  cells.	  Since	  dynasore	  inhibits	  dynamin,	  which	  plays	  indispensable	  role	  in	  both	  endocytosis	  and	  vesicle	  budding	  from	  Golgi,	   the	   increased	   PM-­‐localized	   TRPML	   upon	   activation	   of	   TRPML	   channel	   was	  probably	  due	   to	   lysosome	  exocytosis,	   rather	   than	   the	   trafficking	  of	  newly	   synthesized	  TRPML	   from	   Golgi.	   This	   suggested	   that	   the	   channel	   activity	   of	   TRPML	   might	   be	   a	  contributing	  factor	  to	  lysosome	  exocytosis.	  This	  is	  consistent	  with	  the	  previous	  finding	  that	   the	   constitutive	   active	   TRPML1	   and	   TRPML3	   had	   enhanced	   plasma	   membrane	  localization,	   but	  my	   results	   further	   indicated	   that	   the	   activation	   of	   TRPML	   in	   a	   short	  period	  of	   time	  (1	  hour)	  could	   lead	   to	  considerable	   lysosome	  exocytosis	  and	  evaluated	  quantitatively	   the	   rate	   of	   lysosome	   exocytosis	   in	   the	   presence	   or	   absence	   of	   TRPML	  channel	  activation.	   	   	  	  The	   presence	   of	   a	   TRPML1-­‐independent	   constitutive	   lysosome	   exocytosis	   is	   in	  consistent	  with	   the	   finding	   by	   a	   previous	   study	   showing	   that	   TRPML1	   knockdown	   in	  Hela	   cells	   did	   not	   change	   the	   percentage	   of	   β-­‐galactosidase	   activity	   released	   to	   the	  culture	   medium	   (45).	   It	   remains	   unknown	   what	   mechanism	   drives	   the	   constitutive	  exocytosis.	   Whether	   this	   mechanism	   is	   calcium-­‐mediated,	   or	   lysosomal	  function-­‐mediated	  would	  be	  an	  interesting	  question	  to	  address.	   	   	   	  	  My	  study	  suggests	  that	  trafficking	  of	  TRPML	  channels	  is	  regulated	  at	  multiple	  steps	  after	  being	   synthesized.	   In	  order	   for	  TRPML	  channels	   to	  be	   trafficked	  out	  of	  ER,	   they	  must	  have	  the	  two	  aspartic	  acids	  in	  the	  pore	  area.	  This	  is	  true	  not	  only	  true	  for	  TRPML1	  but	  also	   for	   TRPML3.	   Once	   trafficked	   through	   ER-­‐Golgi	   sorting	   network	   to	   localize	   to	  endolysosomes,	   the	   channels	   will	   undergo	   constant	   plasma	   membrane	   trafficking,	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including	   exocytosis	   and	   endocytosis.	   TRPML1	   and	   its	   mutants	   can	   form	  heteromultimeric	  channels	  with	  TRPML3,	  through	  which	  TRPML1-­‐wt	  as	  well	  as	  7Q,	  KK	  and	   F465L	   mutants	   are	   able	   to	   effectively	   direct	   TRPML3	   internalization.	   However,	  TRPML1-­‐4A	  is	  unable	  to	  affect	  plasma	  membrane	  localized	  TRPML3,	  indicating	  that	  the	  two	   di-­‐leucine	   motifs	   in	   TRPML1	   represent	   the	   molecular	   determinant	   of	   TRPML3	  endocytosis	   and	   trafficking	   to	   endolysosomes.	   This	   is	   consistent	   with	   the	   previous	  finding	   that	   the	   two	   di-­‐leucine	   motifs	   are	   required	   for	   TRPML1	   to	   be	   trafficked	   to	  endolysosome	  (37).	  With	   respect	   to	  exocytosis,	   I	   show	  here	   that	  by	  activating	  TRPML	  channel	   function,	   the	   plasma	   membrane	   localized	   TRPML3	   are	   greatly	   increased,	  presumable	  due	  to	  lysosome	  exocytosis.	   	  	  It	  seems	  that	  the	  two	  di-­‐leucine	  motifs	  and	  TRPML	  channel	  activity	  could	  cooperate	  as	  complementary	  signals.	  The	  activation	  of	  TRPML	  drives	  lysosome	  exocytosis,	  which	  also	  takes	  TRPML	  to	   the	  plasma	  membrane.	  Upon	  trafficking	  to	   the	  plasma	  membrane,	   the	  TRPML	   channel	   function	   is	   inhibited	   by	   PI(4,5)P2	  (48)	   and	   the	   di-­‐leucine	  motifs	   then	  function	  as	  a	  signal	  to	  facilitate	  the	  plasma	  membrane	  localized	  TRPML	  internalization	  through	  calthrin-­‐mediated	  endocytosis	  (Fig.	  7).	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  Fig.	  7.	  Working	  model	  of	  TRPML	  channel	  trafficking	  regulation.	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CHAPTER	   5	   GCaMP	   alters	   subcellular	  
localization	  of	  TRPML1	  and	  LAMP1	  




	   Calcium	   ions	  participate	   in	  multiple	   cellular	  activities,	   serving	  as	  a	   second	  messenger.	  Under	  resting	  conditions,	  Ca2+	  concentration	  is	  low	  in	  the	  cytosol	  but	  is	  several	  orders	  of	  magnitude	   higher	   in	   intracellular	   compartments.	   The	   release	   of	   Ca2+	   from	   these	  compartments,	   such	   as	   ER	   and	   lysosomes,	   triggers	   an	   elevation	   in	   cytosolic	   Ca2+	  concentration	   in	   a	   spatiotemporal	   manner.	   As	   a	   substantial	   population	   of	   Ca2+	  -­‐containing	  intracellular	  vesicles,	  lysosomes	  attract	  particular	  research	  interest	  because	  of	   their	  highly	  dynamic	  nature.	  Lysosomes	  undergo	  constant	   trafficking	  and	   thus	  may	  potentially	  serve	  as	  a	  mobile	  Ca2+	  source.	  Ca2+	  permeable	  channels,	  such	  as	  TRPML1,	  are	  present	   in	   the	   lysosomal	  membrane	  and	  dysfunction	  of	   these	   channels	   causes	   serious	  diseases	   (49).	   Thus,	   understanding	   the	   regulation	   of	   Ca2+	   release	   from	   lysosomes	   is	  imperative	  for	  both	  normal	  cell	  physiology	  and	  designing	  clinical	  therapies.	  	   Studies	  of	   channel	   function	  rely	  essentially	  on	  sensitive	  assays	  able	   to	  detect	   ion	   flow	  through	   the	   channel.	   While	   the	   patch	   clamp	   technique	   is	   widely	   used	   for	   plasma	  membrane	  localized	  channels,	  it	  is	  difficult	  to	  apply	  it	  to	  endolysosomal	  channels,	  albeit	  the	   recently	   developed	   endolysosome	   recording	   method	   that	   exploits	   the	   enlarged	  vacuoles	  either	  naturally	  present	  or	  pharmacologically	   induced	   in	  cells	   (49).	  For	  most	  Ca2+	   permeable	   channels,	   it	   is	   common	   to	   use	   a	   fluorescent	   Ca2+	   indicator	   dye	   to	  monitor	   the	   changes	   in	   intracellular	   Ca2+	   concentration	   by	   a	   spectrofluorometer,	   a	  fluorescence	  plate-­‐reader,	  or	   fluorescence	  microscopy.	  Traditional	  Ca2+	  probes	   include	  small	  chemical	  compounds,	  such	  as	  fluo-­‐4	  and	  fura-­‐2	  (50).	  They	  have	  been	  extensively	  used	  since	  being	  developed	  and	  have	  provided	  rich	  information	  about	  Ca2+	  signaling	  in	  cells.	  However,	  because	  of	  their	  wide	  spread	  distribution	  in	  the	  cytosol	  and	  limited	  ways	  to	   control	   their	   accumulation	   to	   specific	   intracellular	   organelles,	   these	   probes	   are	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mainly	   used	   for	  monitoring	   global	   intracellular	   Ca2+	   concentration	   changes.	   Although	  with	  the	  high	  spatiotemporal	  resolution	  of	  confocal	  microscopy,	  some	  single	  wavelength	  dyes	   can	  be	  used	   to	   reveal	   local	   Ca2+	   dynamics,	   the	   specific	   compartments	   associated	  with	  the	  Ca2+	  signals	  often	  require	  independent	  evaluation.	   	   	  	   Genetically	  encoded	  fluorescence	  Ca2+	  probes	  make	  it	  possible	  to	  target	  the	  indicator	  to	  a	  specific	  subcellular	  location.	  In	  1997,	  Miyawaki	  et	  al.	  engineered	  the	  first	  fluorescent	  probe	  for	  Ca2+	  imaging	  (51).	  Subsequently,	  numerous	  modifications	  were	  introduced	  to	  improve	  the	  probe.	  These	  include	  the	  production	  of	  a	  series	  of	  EGFP-­‐based	  Ca2+	  probes	  named	   GCaMPs,	   which	   contain	   a	   calmodulin	   (CaM)	   at	   the	   C	   terminus	   of	   a	   circularly	  permutated	  EGFP	  and	  an	  engineered	  M13	  domain	  of	  myosin	  light-­‐chain	  kinase	  at	  the	  N	  terminus	  (52,	  53).	  In	  the	  Ca2+-­‐	  free	  environment,	  GCaMPs	  give	  off	  a	  relatively	  low	  basal	  green	  fluorescence;	  however,	  upon	  binding	  Ca2+,	  CaM	  interacts	  with	  M13,	  inducing	  the	  circularly	  permutated	  EGFP	  a	  conformational	  change,	  which	  dramatically	  increases	  the	  fluorescence	   intensity.	  A	  number	  of	  amino	  acid	   substitutions	  have	  been	   introduced	   to	  improve	  the	  performance	  of	  GCaMPs	  (33).	   	  	   Different	   versions	   of	   GCaMPs	   have	   been	   widely	   used	   to	   monitor	   Ca2+	   dynamics	   in	  various	  animal	  models,	   including	  C.	   elegans	   (54),	  Drosophila	   (55),	   zebrafish	   (56),	   and	  mice	   (57).	  At	   the	  cellular	   level,	   a	   recent	   study	  by	  Shen	  et.	   al.	  described	  an	  example	  of	  conjugating	   TRPML1	   to	   GCaMP3	   to	   detect	   Ca2+	   release	   from	   the	   lysosomes	   (36).	  However,	   GCaMP3	   represents	   an	   earlier	   version	   of	   the	   GCaMP	   series	   that	   has	   a	  substantially	   lower	  dynamic	  range	   in	   fluorescence	   intensity	  change	  upon	  Ca2+	  binding	  than	   the	   more	   advanced	   GCaMP5.	   The	   fluorescence	   signal	   produced	   by	  TRPML1-­‐GCaMP3,	   therefore,	   was	   rather	   weak	   upon	   stimulation	   of	   lysosome	   Ca2+	  release.	  	  	   In	   an	   effort	   to	   generate	   better	   probes	   to	   detect	   Ca2+	   release	   from	   lysosomes,	   I	  conjugated	  GCaMP5G	  to	  the	  C-­‐terminus	  of	  LAMP1	  or	  TRPML1.	  GCaMP5G	  was	  described	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5.2.1	  TRPML1-­‐GCaMP	  and	  LAMP1-­‐GCaMP	  failed	  to	  distinguish	  
calcium	  release	  from	  specific	  compartments.	  
	  To	  evaluate	   the	   specificity	  of	   the	  GCaMP	  probes,	   stimulants	   intended	   to	  mobilize	  Ca2+	  from	  different	   intracellular	   compartments	   to	   cytosol	  were	   applied	   to	   cells	   transfected	  with	  TRPML-­‐GCaMP5G.	  As	  a	  control,	  a	  previously	  reported	  TRPML1-­‐GCaMP3	  construct	  (36),	  obtained	  from	  Dr.	  Haoxing	  Xu’s	  laboratory,	  was	  used.	   	   	  	   Carbachol	  is	  the	  ligand	  for	  muscarinic	  acetylcholine	  receptors.	  The	  HEK293	  cells	  that	  I	  used	  endogenously	  express	  Gq-­‐coupled	  muscarinic	   receptors	  and	  upon	  stimulation	  by	  carbachol,	   they	   activate	   phospholipase	   C,	   leading	   to	   the	   breakdown	   of	   PI(4,5)P2	   and	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production	  of	   IP3.	   IP3	  activates	   IP3	  receptors	  on	   the	  ER	   to	  mobilize	  Ca2+	   from	  the	  ER	  store.	  Therefore,	  carbachol	  mainly	  releases	  Ca2+	  from	  ER.	   	  	   Glycyl-­‐L-­‐phenylalanine	   2-­‐naphthylamide	   (GPN),	   is	   a	   substrate	   for	   Cathepsin	   C,	   a	  lysosomal	  luminal	  cysteine	  protease.	  When	  hydrolyzed	  by	  cathepsin	  C,	  it	  degrades	  into	  fragments	  that	  are	  unable	  to	  diffuse	  through	  the	  lysosomal	  membrane.	  This	  causes	  the	  lysosome	  membrane	  to	  disrupt	  and	  loss	  of	  lysosomal	  contents,	  including	  Ca2+.	  Therefore,	  GPN	  specifically	  induces	  Ca2+	  releases	  from	  lysosomes	  (58).	  	   As	   described	   in	   the	   previous	   chapters,	   ML-­‐SA1	   is	   a	   synthetic	   TRPML	   agonist	   that	  activates	  both	  mammalian	  TRPML1	  and	  TRPML3	  (49).	  Different	   from	  the	  endogenous	  TRPML	  agonist	  PI(3,5)P2,	  which	  activates	  TRPML	  channels	  in	  a	  pH	  dependent	  manner,	  ML-­‐SA1	  activates	  TRPML	  channels	  regardless	  of	  the	  pH.	  Therefore,	  ML-­‐SA1	  can	  induce	  Ca2+	  releases	  from	  any	  TRPML-­‐containing	  compartments.	   	  	   In	   the	  Ca2+-­‐free	  extracellular	   solution,	  which	  minimizes	   the	  contribution	  of	  Ca2+	   influx	  from	   outside	   of	   the	   cell,	   application	   of	   100	   µM	   carbachol	   evoked,	   on	   average,	   about	  one-­‐fold	  increase	  in	  fluorescence	  intensity	  in	  cells	  transfected	  with	  TRPML1-­‐GCaMP5G	  .	  In	   cells	   transfected	  with	   TRPML1-­‐GCaMP3,	   carbachol	   also	   increased	   the	   fluorescence	  intensity	   by	  ~30%.	   The	   fluorescence	   intensity	   increase	   in	   response	   to	   carbachol	  was	  even	  larger	  in	  cells	  transfected	  with	  LAMP1-­‐GCaMP5G,	  reaching	  about	  two-­‐folds	  at	  the	  peak	  of	  the	  response	  (Fig.	  8A,	  8B,	  8C).	  Therefore,	  although	  these	  probes	  were	  intended	  to	  measure	  Ca2+	  release	   from	  endolysosomes,	   they	  also	  detected	  ER	  Ca2+	  mobilization.	  The	  more	  pronounced	   increase	   in	   fluorescence	   intensity	   for	   the	  GCaMP5G	  probe	   than	  the	  GCaMP3	  probe	  is	  consistent	  with	  the	  improved	  dynamic	  range	  of	  the	  newer	  GCaMP	  version	   (33).	   Of	   course,	   these	   results	   do	   not	   exclude	   the	   possibility	   that	   carbachol	  treatment	  might	  also	  mobilize	  Ca2+	  from	  endolysosomes.	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  Fig.	  8.	  A)	  Fluorescence	  changes	  of	  HEK293	  cells	  transfected	  with	  TRPML1-­‐GCaMP5G	  upon	  stimulation	  by	  carbachol	  (CCh	  100	  µM)	  in	  a	  nominally	  Ca2+-­‐free	  extracellular	  solution	  (measured	  as	  GCaMP	  fluorescence	  over	  basal	  fluorescence	  F0;	  F/F0).	  B)	  Fluorescence	  changes	  of	  HEK293	  cells	  transfected	  with	  TRPML1-­‐GCaMP3	  upon	  stimulation	  by	  CCh	  (100	  µM)	  in	  a	  nominally	  Ca2+-­‐free	  extracellular	  solution.	  C)	  Comparison	  of	  peak	  fluorescence	  changes	  for	  conditions	  shown	  in	  A)	  and	  B).	  D)	  Fluorescence	  changes	  of	  HEK293	  cells	  transfected	  with	  TRPML1-­‐GCaMP5G	  upon	  stimulation	  by	  ML-­‐SA1	  (20	  µM)	  in	  a	  nominally	  Ca2+-­‐free	  extracellular	  solution.	  E)	  Fluorescence	  changes	  of	  HEK293	  cells	  transfected	  with	  TRPML1-­‐GCaMP3	  upon	  stimulation	  by	  ML-­‐SA1	  (20	  µM)	  in	  a	  nominally	  Ca2+-­‐free	  extracellular	  solution.	  F)	  Comparison	  of	  peak	  fluorescence	  changes	  for	  conditions	  shown	  in	  D)	  and	  E).	  G)	  Fluorescence	  changes	  of	  HEK293	  cells	  transfected	  with	  TRPML1-­‐GCaMP5G	  upon	  stimulation	  by	  ML-­‐SA1	  (20	  µM)	  in	  an	  extracellular	  solution	  containing	  2	  mM	  Ca2+.	  H)	  Fluorescence	  changes	  of	  HEK293	  cells	  transfected	  with	  TRPML1-­‐GCaMP3	  upon	  stimulation	  by	  ML-­‐SA1	  (20	  µM)	  in	  an	  extracellular	  solution	  containing	  2	  mM	  Ca2+.	  I)	  Comparison	  of	  peak	  fluorescence	  changes	  for	  conditions	  shown	  in	  G)	  and	  H).	  J)	  Fluorescence	  change	  of	  HEK293	  cells	  transfected	  with	  TRPML1-­‐GCaMP5G	  upon	  stimulation	  by	  GPN	  (100	  µM)	  in	  a	  nominally	  Ca2+-­‐free	  extracellular	  solution.	  K)	  Fluorescence	  change	  of	  HEK293	  cells	  transfected	  with	  TRPML1-­‐GCaMP3	  upon	  stimulation	  by	  GPN	  (100	  µM)	  in	  a	  nominally	  Ca2+-­‐free	  extracellular	  solution.	  L)	  Comparison	  of	  peak	  fluorescence	  change.	  M-­‐N)	  Fluorescence	  changes	  of	  HEK293	  cells	  transfected	  with	  LAMP1-­‐GCaMP	  upon	  stimulation	  by	  100	  µM	  CCh	  (M)	  or	  100	  µM	  GPN	  (N)	  in	  a	  nominally	  Ca2+-­‐free	  extracellular	  solution.	  Data	  in	  the	  summary	  plots	  represent	  mean	  values	  ±	  SEM.
	  46	  
5.2.2	  TRPML1-­‐GCaMP5G	  exhibited	  altered	  subcellular	  
localization	  than	  TRPML1-­‐GFP 	   One	  of	  the	  possible	  causes	  for	  the	  lack	  of	  probe	  specificity	  in	  detecting	  Ca2+	  release	  from	  the	  desired	  subcellular	  compartment	  could	  be	  due	  to	  the	  lack	  of	  extensive	  targeting	  of	  the	   GCaMP-­‐fusion	   protein	   to	   the	   intended	   organelles.	   In	   cells	   overexpressing	  TRPML1-­‐GCaMP5G,	  I	  observed	  bright	  green	  bubbles	  (Fig.	  9A),	  which	  did	  not	  appear	  in	  cells	  that	  expressed	  TRPML1-­‐GFP	  (Fig.	  9B).	  Three	  possible	  explanations	  could	  account	  for	   the	   difference	   between	   TRPML1-­‐GCaMP5G	   and	   TRPML1-­‐GFP	   in	   subcellular	  distribution:	  1)	   the	   conjugation	  of	  GCaMP5G	   to	  TRPML1	  caused	  a	   change	  of	   lysosome	  distribution	   and	   biogenesis	   through	   disturbing	   endolysosome	   trafficking;	   2)	   the	  conjugated	   GCaMP5G	   directed	   TRPML1	   to	   different	   subcellular	   targets;	   3)	   different	  from	   GFP,	   the	   fluorescence	   intensity	   of	   GCaMP5G	   reflects	   not	   only	   where	   the	   fusion	  protein	   exists	   but	   also	   where	   the	   Ca2+	   concentration	   is	   high;	   hence	   the	   bright	   green	  bubbles	  might	  indicate	  the	  locations	  of	  Ca2+	  hot	  spots	  over	  the	  weak	  background	  signals	  representing	  endolysosome	  localized	  TRPML1-­‐GCaMP5G	  in	  low	  Ca2+	  environment.	  	  To	  distinguish	  these	  possbilities,	  I	  stained	  the	  cells	  transfected	  with	  TRPML1-­‐GCaMP5G	  or	   TRPML1-­‐GFP	   using	   antibodies	   against	   GFP	   and	   LAMP2,	   a	   lysosomal	   membrane	  marker.	  GCaMPs	  were	  essentially	  recombinant	  proteins	  containing	  GFP	  and	  calmodulin.	  Therefore,	  an	  rabbit	  anti-­‐GFP	  antibody	  can	  readily	  recognize	  GCaMPs	  and	  the	  expressed	  fusion	   proteins	   can	   be	   visualized,	   irrespective	   of	   their	   Ca2+-­‐binding	   status,	   by	   a	  secondary	  antibody	  conjugated	  with	  a	  red	  fluorescence	  probe,	  for	  example	  Alexa	  Fluor	  568.	  Therefore,	  staining	  with	  the	  anti-­‐GFP	  antibody	  was	  used	  to	  reveal	  the	  subcellular	  distribution	  of	  the	  expressed	  TRPML1-­‐GCaMP5G	  without	  the	  interference	  by	  local	  Ca2+	  levels.	   To	   label	   lysosomes,	   the	   cells	   were	   also	   stained	   with	   a	   mouse	   monoclonal	  anti-­‐LAMP2	   antibody,	   which	   was	   followed	   by	   staining	   with	   a	   Cy5-­‐conjugated	  anti-­‐mouse	   secondary	  antibody.	   I	   found	   that	   the	  expression	  of	  TRPML1-­‐GCaMP5G	  did	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not	  obviously	  alter	  the	  lysosome	  morphology	  and	  distribution	  patterns,	  as	  revealed	  by	  LAMP2	  staining.	  However,	   the	  staining	  by	  anti-­‐GFP	  still	  suggested	  a	  rather	   incomplete	  colocalization	  of	  TRPML1-­‐GCaMP5G	  with	  LAMP2,	  suggesting	  pronouced	  non-­‐lysosomal	  localization	  of	  this	  fusion	  protein,	  which	  differed	  markedly	  from	  TRPML1-­‐GFP	  (Fig.	  9C).	  To	   quantify	   the	   colocalization	   between	   GFP	   and	   LAMP2	   signals,	   I	   used	   Pearson’s	  colocalization	   analysis	   and	   the	   results	   indicated	   a	   significant	   difference	   between	  TRPML1-­‐GCaMP5G	   versus	   LAMP2	   (0.58±0.02)	   and	   TRPML1-­‐GFP	   versus	   LAMP2	  (0.88±0.02)	  (Fig.	  9E).	   	  	  I	   also	   detected	   pronounced	   localization	   of	   TRPML1-­‐GCaMP5G	   on	   plasma	   membrane,	  which	   differed	   markedly	   from	   the	   rather	   extensively	   endolysosome	   localized	  TRPML1-­‐GFP.	   This	   would	   be	   consistent	   with	   the	   pronounced	   response	   of	  TRPML1-­‐GCaMP5G	   to	   bath	   applied	   TRPML	   agonist	   ML-­‐SA1	   in	   the	   presence	   of	  extracellular	   Ca2+	   in	   the	   imaging	   assay	   (Fig.	   8G).	   To	   further	   confirm	   that	  TRPML1-­‐GCaMP5G	   formed	   functional	   channels	   on	   the	   plasma	   membrane,	   whole-­‐cell	  patch	  clamp	  assay	  was	  used	  to	  record	  ionic	  currents	  elicited	  by	  ML-­‐SA1.	  As	  expected,	  an	  inwardly	   rectifying	   current	   was	   readily	   evoked	   by	   ML-­‐SA1	   (20	   µM)	   in	   cells	   that	  expressed	   TRPML1-­‐GCaMP5G,	   but	   not	   those	   that	   expressed	   TRPML1-­‐GFP.	   Taken	  together,	  my	  data	  established	  the	  alteration	  of	  TRPML1	  subcellular	   localization	  by	   the	  conjugation	  of	  GCaMP5G	  (Fig.	  9D,	  9F)	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  Fig.	   9.	   Confocal	   microscopy	   analysis	   of	   subcellular	   localization	   of	   TRPML1-­‐GCaMP.	   A)	  HEK293	   cells	   transfected	   with	   TRPML1-­‐GCaMP5G	   and	   LAMP1-­‐mCherry.	   B)	   HEK293	   cells	  transfected	   with	   TRPML1-­‐GFP	   and	   LAMP1-­‐mCherry.	   C)	   HEK293	   cells	   transfected	   with	  TRPML1-­‐GCaMP5G	   and	   immunostained	   with	   anti-­‐GFP	   and	   anti-­‐LAMP2.	   D)	   Pearson’s	  colocalization	  analysis	  of	  TRPML1-­‐GCaMP5G	  and	  TRPML1-­‐GFP	  vs	  LAMP2.	  E-­‐G)	  Whole-­‐cell	  patch	   clamp	   recording	   of	   TRPML1-­‐GCaMP5G	   transfected	   cells.	   The	   whole-­‐cell	   data	   were	  provided	  by	  Dr.	  Xinghua	  Feng.	  Data	  represent	  mean	  values	  ±	  SEM.	  Scale	  bar	  represents	  10	  μm.	  















































































5.2.3	  LAMP1-­‐GCaMP5G	  showed	  increased	  plasma	  membrane	  
localization	  
	   Similarly,	   upon	   examination	   of	   the	   subcellular	   localization	   of	   LAMP1-­‐GCaMP5G	   by	  staining	  with	  the	  anti-­‐GFP	  and	  LAMP2	  antibodies	  as	  used	  above	  for	  TRPML1-­‐GCaMP5G,	  I	   found	   that	   LAMP1-­‐GCaMP5G	   also	   became	   pronouncedly	   targeted	   to	   the	   plasma	  membrane	  (Fig.	  10A).	  This	  was	   in	  a	  sharp	  contrast	  with	  LAMP1-­‐GFP,	  which	  showed	  a	  near	   extensive	   lysosomal	   localization.	   Neither	   LAMP1-­‐GCaMP5G	   nor	   LAMP1-­‐GFP	  obviously	   altered	   lysosome	   morphology	   or	   distribution	   patterns	   as	   shown	   by	   the	  staining	   with	   LAMP2	   (Fig.	   10B).	   Quantification	   results	   from	   Pearson’s	   colocalization	  analysis	  also	  supported	  that	  LAMP1-­‐GCaMP5G	  was	  more	  poorly	  targeted	  to	  lysosomes	  than	  LAMP1-­‐GFP	  (Fig.	  10D).	   	  	  To	  assess	  the	  relative	  amount	  of	  plasma	  membrane	  localized	  LAMP1-­‐GCaMP5G,	  I	  used	  a	  membrane	  impermeable	  biotinylation	  reagent	  to	  label	  cell	  surface	  proteins,	  which	  was	  followed	  by	  pulling	  down	  the	   labeled	  proteins	  with	  avidin	  agarose	  beads.	  The	  relative	  levels	  of	  cell	  surface	  expressed	  proteins	  were	  estimated	  by	  immunoblotting.	  The	  results	  showed	  that	  the	  relative	  amount	  of	  plasma	  membrane	  localized	  LAMP1-­‐GCaMP5G	  was	  ~10-­‐fold	   more	   than	   that	   of	   LAMP1-­‐GFP	   (Fig.	   10C).	   Taken	   together,	   my	   data	  demonstrated	  that	  the	  subcellular	  localization	  of	  LAMP1	  was	  changed	  upon	  conjugation	  with	  GCaMP5G.	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5.3	  Discussion	  
	   The	  use	  of	  fluorescence	  proteins	  has	  greatly	  facilitated	  life	  science	  research.	  A	  substantial	  amount	  of	  work	  has	  been	  put	  into	  improving	  the	  fluorescence	  protein	  tags	  (59),	  which	  has	  benefited	  cytodynamic	  studies,	  including	  those	  for	  protein	  trafficking	  and	  protein-­‐protein	  interaction,	  as	  well	  as	  biochemical	  studies.	  Fluorescence	  protein	  based	  probes	  have	  also	  been	  developed	  to	  detect	  small	  molecules,	  such	  as	  PI(3,5)P2	  (60)	  and	  phosphatidic	  acid	  (61),	  in	  addition	  to	  the	  large	  number	  of	  Ca2+	  probes	  including	  GCaMPs.	   	  	  One	  of	  the	  major	  advantages	  of	  the	  genetically	  encoded	  fluorescence	  protein	  probes	  is	  their	  ability	  to	  target	  to	  specific	  cellular	  locations	  based	  on	  the	  proteins	  they	  are	  fused	  with.	  While	  in	  majority	  of	  the	  cases,	  the	  fluorescence	  protein	  tagged	  proteins	  faithfully	  reside	  in	  their	  normal	  subcellular	  regions,	  occasionally,	  the	  addition	  of	  the	  tag,	  and	  perhaps	  overexpression	  of	  the	  protein	  as	  well,	  could	  also	  affect	  the	  subcellular	  localization	  of	  the	  original	  protein.	  Signal	  peptides	  or	  targeting	  sequences,	  which	  usually	  reside	  in	  the	  N-­‐	  or	  C-­‐	  terminus	  of	  a	  protein	  (62)	  represent	  a	  highly	  conservative	  mechanism	  by	  which	  proteins,	  especially	  membrane	  proteins,	  utilize	  for	  transportation	  to	  their	  proper	  subcellular	  localations.	   	   The	  conjugation	  of	  a	  tag	  could	  interfere	  with	  the	  recognition	  of	  the	  signal	  peptides	  and	  therefore	  interrupt	  the	  proper	  trafficking.	  As	  an	  example,	  TRPML3	  became	  localized	  in	  the	  ER	  if	  an	  mCherry	  tag	  was	  conjugated	  to	  its	  C	  terminus,	  but	  was	  localized	  in	  lysosomes	  and	  plasma	  membrane	  when	  the	  tag	  was	  added	  at	  is	  the	  N	  terminus.	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While	  GCaMPs	  are	  promising	  tools	  to	  provide	  informative	  details	  on	  intracellular	  Ca2+	  signaling,	  the	  possibility	  that	  they	  may	  alter	  the	  subcellular	  localization	  of	  the	  fusion	  protein	  would	  urge	  researchers	  to	  examine	  the	  localization	  before	  using	  it.	  Because	  the	  fluorescence	  signal	  of	  a	  GCaMP	  is	  influenced	  by	  the	  Ca2+	  concentration	  in	  the	  local	  environment,	  I	  relied	  on	  using	  an	  anti-­‐GFP	  antibody	  and	  a	  secondary	  antibody	  conjugated	  with	  a	  non-­‐green	  (red)	  fluorescence	  color	  to	  reveal	  the	  localization	  of	  GCaMP5G	  fusion	  proteins.	  My	  results	  indicate	  that	  at	  least	  for	  two	  lysosomal	  membrane	  proteins,	  TRPML1	  and	  LAMP1,	  the	  fusion	  of	  GCaMP5G	  to	  the	  cytoplasmic	  side	  can	  significantly	  disrupt,	  although	  not	  completely	  eliminate,	  the	  endolysosomal	  targeting	  and	  promote	  translocaion	  to	  plasma	  membrane.	  This	  appears	  to	  be	  specific	  for	  GCaMP	  as	  the	  fusion	  of	  GFP	  did	  not	  have	  such	  an	  effect.	  Although	  this	  alteration	  in	  protein	  subcellular	  distribution	  may	  not	  be	  a	  general	  effect	  of	  GCaMPs,	  my	  results	  suggest	  that	  a	  careful	  evaluation	  of	  subcellular	  localization	  of	  the	  fusion	  protein	  is	  a	  necessary	  step	  when	  using	  a	  GCaMP	  to	  measure	  organelles	  specific	  Ca2+	  signals.	   	  	  I	  ran	  a	  series	  of	  Ca2+	  imaging	  experiments	  to	  compare	  the	  utility	  of	  my	  GCaMP5G	  constructs	  with	  the	  reported	  construct	  (TRPML1-­‐GCaMP3).	  In	  all	  cases,	  the	  percent	  increases	  in	  fluorescence	  intensity	  upon	  stimulation	  were	  higher	  with	  my	  TRPML1-­‐GCaMP5G	  construct	  than	  the	  TRPML1-­‐GCaMP3	  construct.	  Most	  likely,	  this	  difference	  was	  due	  to	  the	  improved	  dynamic	  range	  and	  brighter	  fluorescence	  signal	  of	  the	  more	  advanced	  GCaMP5G	  as	  compared	  to	  its	  predecessor	  GCaMP3.	  However,	  it	  cannot	  be	  excluded	  that	  the	  less	  specific	  subcellular	  distribution	  of	  TRPML1-­‐GCaMP5G	  than	  TRPML1-­‐GCaMP3	  also	  contributed	  to	  the	  difference	  in	  the	  response.	   	  	  The	  nature	  of	  the	  bright	  green	  bubbles	  in	  TRPML1-­‐GCaMP5G	  transfected	  cell	  remains	  unknown.	  The	  intensity	  of	  GCaMP	  is	  determined	  by	  two	  factors:	  the	  abundance	  of	  the	  protein	  and	  the	  Ca2+	  concentration.	  Since	  immunostaining	  of	  TRPML1-­‐GCaMP5G	  with	  the	  anti-­‐GFP	  antibody	  revealed	  no	  brighter	  red	  signal	  in	  regions	  where	  the	  bright	  green	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vesicles	  reside	  than	  the	  surrounding	  areas,	  the	  observed	  bright	  green	  signal	  most	  likely	  arose	  from	  high	  Ca2+	  concentrations	  in	  these	  vesicles.	  Given	  the	  low	  cytosolic	  calcium	  concentration	  (~100	  nM),	  it	  would	  be	  possible	  that	  the	  bright	  green	  signal	  came	  from	  GCaMP5G	  that	  was	  trapped	  inside	  vesicles	  that	  contained	  high	  Ca2+.	  However,	  because	  the	  fluorescence	  signal	  of	  GCaMP5G	  is	  strongly	  quenched	  by	  low	  pH,	  the	  luminal	  pH	  of	  these	  vesicles	  would	  also	  have	  to	  be	  relatively	  neutral.	  One	  possibility	  would	  be	  multivesicular	  bodies	  known	  to	  exist	  during	  the	  process	  of	  endocytosis.	  Alternatively,	  these	  could	  represent	  autophagosomes	  and	  amphisomes.	  More	  extensive	  studies	  are	  needed	  to	  define	  the	  nature	  of	  these	  vesicles.	   	  	  I	  also	  noticed	  that	  when	  conjugated	  with	  GCaMP5G,	  both	  TRPML1	  and	  LAMP1	  showed	  increased	  plasma	  membrane	  localization.	  These	  could	  result	  from	  either	  increased	  exocytosis	  or	  decreased	  endocytosis	  of	  the	  fusion	  protein-­‐containing	  vesicles.	  If	  there	  were	  increased	  lysosome	  exocytosis,	  I	  would	  also	  expect	  a	  greater	  presence	  of	  the	  lysosome	  marker,	  such	  as	  LAMP2,	  on	  the	  plasma	  membrane,	  which	  however,	  did	  not	  happen.	  Therefore,	  it	  is	  likely	  that	  the	  endocytosis	  of	  the	  GCaMP5G	  conjugated	  lysosomal	  membrane	  proteins	  was	  disturbed.	  This	  may	  indicate	  a	  role	  of	  Ca2+	  in	  the	  regulation	  of	  internalization	  of	  lysosomal	  membrane	  proteins.	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The	  present	  study	  on	  TRPML3	  trafficking	  has	  discovered	  three	  steps	  of	  regulation	  of	  TRPML	  channel	  trafficking.	  Two	  conserved	  aspartic	  acids	  in	  the	  pore	  region	  of	  TRPML	  channels	  are	  important	  for	  the	  channel	  to	  be	  trafficked	  out	  of	  ER;	  TRPML	  internalization	  is	  mediated	  by	  the	  two	  di-­‐leucine	  motifs	  that	  reside	  in	  TRPML1;	  exocytosis	  of	  TRPML-­‐containing	  vesicles	  is	  facilitated	  by	  TRPML	  channel	  activation,	  but	  not	  compromised	  by	  TRPML	  channel	  inhibition.	  Since	  TRPML	  channels	  are	  lysosomal	  membrane	  proteins,	  the	  trafficking	  of	  TRPML	  largely	  represents	  lysosomes	  trafficking,	  which	  is	  very	  important	  for	  lysosomes	  to	  carry	  out	  degradation	  function.	   	  	  Future	  work	  based	  on	  this	  study	  includes	  investigating	  the	  mechanism	  that	  regulates	  the	  constitutive	  lysosome	  exocytosis	  and	  how	  the	  newly	  synthesized	  TRPML	  channels	  are	  targeted	  to	  the	  lysosomes,	  for	  example,	  whether	  TRPML	  channels	  are	  trafficked	  to	  the	  plasma	  membrane	  first,	  then	  internalized	  to	  the	  endolysosomes	  or	  are	  trafficked	  to	  the	  endolysosomes	  directly,	  or	  both.	  The	  role	  of	  TRPML	  channels	  functionality	  in	  lysosome	  exocytosis,	  as	  illustrated	  in	  this	  thesis,	  indicates	  the	  functionality	  of	  TRPML	  might	  be	  involved	  in	  multiple	  cellular	  activities	  that	  require	  lysosome	  exocytosis,	  and	  the	  roles	  of	  TRPML	  channel	  in	  such	  activities	  represent	  interest	  topics	  to	  explore.	  There	  is	  no	  di-­‐leucine	  motif	  in	  TRPML3;	  however,	  in	  HEK293	  cells	  overexpressing	  TRPML3,	  a	  large	  portion	  of	  TRPML3	  was	  localized	  to	  endolysosomes,	  indicating	  there	  is	  an	  unknown	  pathway	  governing	  the	  trafficking	  of	  TRPML3	  to	  endocytic	  vesicles.	  Such	  a	  mechanism	  is	  also	  interesting	  to	  investigate.	   	  	  The	  conjugation	  of	  GCaMP5G	  disrupted	  endolysosome	  trafficking	  of	  two	  lysosomal	  membrane	  proteins,	  TRPML1	  and	  LAMP1.	  However,	  this	  does	  not	  necessarily	  mean	  the	  probes	  I	  generated	  are	  useless.	  Depending	  on	  how	  the	  assay	  is	  designed,	  the	  probes	  could	  be	  fantastic	  tools.	  For	  example,	  HEK293	  cells	  transfected	  with	  the	  preferentially	  plasma	  membrane	  localized	  TRPML1-­‐GCaMP5G	  could	  be	  used	  to	  screen	  for	  TRPML1	  agonists	  and/or	  antagonists.	  The	  plasma	  membrane	  localized	  LAMP1	  could	  be	  a	  marker	  of	  plasma	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membrane.	  It	  would	  be	  also	  interesting	  to	  understand	  the	  mechanism	  why	  the	  GCaMP	  conjugated	  proteins	  were	  mislocalized,	  and	  there	  are	  at	  least	  two	  possibilities.	  First,	  the	  relative	  position	  of	  GCaMP	  might	  interrupt	  TRPML1	  interaction	  with	  proteins	  that	  are	  responsible	  for	  membrane	  protein	  trafficking,	  such	  as	  adaptor	  proteins;	  second,	  the	  calmodulin	  included	  in	  the	  GCaMP	  might	  affect	  the	  local	  calcium	  signaling,	  which	  is	  involved	  in	  calthrin	  mediated	  endocytosis	  (63).	  Understanding	  such	  a	  mechanism	  will	  not	  only	  allow	  me	  to	  develop	  better	  indicators	  for	  lysosomal	  calcium	  release,	  but	  also	  elucidate	  how	  lysosome	  biogenesis	  is	  achieved	  with	  the	  trafficking	  of	  lysosomal	  membrane	  proteins.	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